(ROOT
  (S
    (NP
      (NP (NN Resistance))
      (VP
        (PP (TO to)
          (NP
            (NP
              (NP (NN IL-10) (NN inhibition))
              (PP (IN of)
                (NP (JJ interferon) (NN gamma) (NN production))))
            (CC and)
            (NP
              (NP (NN expression))
              (PP (IN of)
                (NP
                  (NP (NN suppressor))
                  (PP (IN of)
                    (NP (NN cytokine))))))))
        (VBG signaling)
        (NP
          (NP (CD 1))
          (PP (IN in)
            (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
        (PP (IN from)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP (JJ rheumatoid) (NN arthritis) (NNP Abstract) (NNP IL-10)))))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB block)
                (NP (DT the) (JJ antigen-specific) (NNP T-cell) (NN cytokine) (NN response))
                (PP (IN by)
                  (S
                    (VP (VBG inhibiting)
                      (NP
                        (NP (DT the) (NN CD28))
                        (VP (VBG signaling)
                          (ADVP (RB pathway)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ peripheral) (NN blood) (NNP CD4) (NNP +) (NNP T) (NNS cells))
            (PP (IN from)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP
                    (NP (JJ active) (JJ rheumatoid) (NN arthritis))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP RA))
                      (-RRB- -RRB-)))))))
          (VP (VBD were)
            (ADJP (JJ able)
              (S
                (VP (TO to)
                  (VP (VB produce)
                    (NP
                      (NP (JJR greater) (NNS amounts))
                      (PP (IN of)
                        (NP (NN interferon) (NN gamma))))
                    (PP (IN after)
                      (NP
                        (NP (NNP CD3))
                        (CC and)
                        (NP (CD CD28)
                          (ADJP (JJ costimulation)
                            (PP (IN in)
                              (NP
                                (NP (DT the) (NN presence))
                                (PP (IN of)
                                  (NP
                                    (NP (CD 1) (JJ ng/ml) (NN IL-10))
                                    (SBAR (IN than)
                                      (S
                                        (VP (VBD were)
                                          (NP (JJ normal) (NN control))))))))))
                          (JJ CD4) (JJ +) (NN T) (NNS cells))))))))
            (, ,)
            (SBAR (IN although)
              (S
                (NP
                  (NP (PRP$ their) (NN surface) (NN expression))
                  (PP (IN of)
                    (NP (DT the)
                      (ADJP (NN type) (CD 1))
                      (NN IL-10) (NN receptor))))
                (VP (VBD was)
                  (VP (VBN increased)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN phosphorylation))
        (PP (IN of)
          (NP
            (NP (NN signal) (NN transducer)
              (CC and)
              (NN activator))
            (PP (IN of)
              (NP (NN transcription) (CD 3))))))
      (VP (VBD was)
        (VP (VBN sustained)
          (PP (IN in)
            (NP
              (NP (DT both) (NN blood))
              (CC and)
              (NP
                (NP (JJ synovial) (NN tissue) (NNP CD4) (NNP +) (NNP T) (NNS cells))
                (PP (IN of)
                  (NP (NNP RA)))))))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBD was) (RB not)
        (VP (VBN augmented)
          (PP (IN by)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (CD 1) (JJ ng/ml) (NN IL-10))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Sera))
      (PP (IN from)
        (NP (NNP RA) (NNS patients))))
    (VP (VBN induced)
      (NP
        (NP (NN signal) (NN transducer)
          (CC and)
          (NN activator))
        (PP (IN of)
          (NP (NN transcription) (CD 3) (NN phosphorylation))))
      (PP (IN in)
        (NP
          (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBD was)
                (ADVP (RB mostly))
                (VP (VBN abolished)
                  (PP (IN by)
                    (S
                      (VP (VBG neutralizing)
                        (NP (JJ anti-IL-6) (NN antibody))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Preincubation))
      (PP (IN of)
        (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
      (PP (IN with)
        (NP (NN IL-6))))
    (VP (VBD reduced)
      (NP
        (NP (NN IL-10-mediated) (NN inhibition))
        (PP (IN of)
          (NP (JJ interferon) (NN gamma) (NN production)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Blood) (NNP CD4) (NNP +) (NNP T) (NNS cells))
      (PP (IN from)
        (NP (NNP RA) (NNS patients))))
    (VP (VBD contained)
      (NP
        (NP (JJR higher) (NNS levels))
        (PP (IN of)
          (NP
            (NP (NN suppressor))
            (PP (IN of)
              (NP (NN cytokine))))))
      (S
        (VP (VBG signaling)
          (NP
            (NP (CD 1))
            (PP (CC but)
              (NP
                (NP (JJR lower) (NNS levels))
                (PP (IN of)
                  (NP
                    (NP (NN suppressor))
                    (PP (IN of)
                      (NP
                        (ADJP (JJ cytokine)
                          (S
                            (VP (VBG signaling)
                              (NP
                                (NP (CD 3) (NN mRNA))
                                (PP (VBN compared)
                                  (PP (IN with)
                                    (NP (NN control) (NNP CD4) (NNP +) (NNP T))))))))
                        (NNS cells))))))))))
      (, ,)
      (SBAR (IN as)
        (S
          (VP (VBN determined)
            (PP (IN by)
              (NP (JJ real-time) (NNP PCR)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT These) (NNS results))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))
            (VP (VBP become)
              (ADJP (JJ resistant)
                (PP (TO to)
                  (NP
                    (NP (DT the) (JJ immunosuppressive) (NN effect))
                    (PP (IN of)
                      (NP
                        (NP (NN IL-10))
                        (PP (IN before)
                          (NP (NN migration))))))))
              (PP (IN into)
                (NP (JJ synovial) (NN tissue))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT this) (VBN impaired) (NN IL-10))
        (VP (VBG signaling)))
      (VP (MD may)
        (VP (VB be)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP
                  (NP (JJ sustained) (NN signal) (NN transducer)
                    (CC and)
                    (NN activator))
                  (PP (IN of)
                    (NP (NN transcription) (CD 3) (NN activation))))
                (CC and)
                (NP
                  (NP (NN suppressor))
                  (PP (IN of)
                    (NP (NN cytokine))))))
            (S
              (VP (VBG signaling)
                (NP (CD 1) (NN induction))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Introduction) (NNP IL-10))
    (VP (VBZ is)
      (NP
        (NP (DT a) (JJ key) (NN cytokine))
        (PP (IN in)
          (S
            (VP (VBG regulating)
              (NP (JJ inflammatory) (NNS responses))
              (, ,)
              (PP
                (ADVP (RB mainly))
                (IN by)
                (S
                  (VP (VBG inhibiting)
                    (NP
                      (NP (DT the) (NN production)
                        (CC and)
                        (NN function))
                      (PP (IN of)
                        (NP (JJ proinflammatory) (NNS cytokines))))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-10))
    (VP (VBZ binds)
      (PP (TO to)
        (NP
          (NP (DT the) (NN IL-10) (NN receptor)
            (PRN (-LRB- -LRB-)
              (NP (NNP IL-10R))
              (-RRB- -RRB-))
            (NN complex))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBZ is)
                (VP (VBN composed)
                  (PP (IN of)
                    (NP
                      (NP (CD two) (NNS subunits))
                      (, ,)
                      (NP
                        (NP (DT the) (JJ primary) (JJ ligand-binding) (NN component) (NN type))
                        (NP (CD 1) (NN IL-10R)
                          (PRN (-LRB- -LRB-)
                            (NP (NNP IL-10R1))
                            (-RRB- -RRB-))))
                      (CC and)
                      (NP
                        (NP (DT the) (JJ accessory) (NN component) (NN type))
                        (NP (CD 2) (NNP IL-10R) (NNP -LSB-) (CD 1) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN interaction))
      (PP (IN of)
        (NP (NN IL-10)
          (CC and)
          (NN IL-10R))))
    (VP (VBZ engages)
      (NP
        (NP (DT the) (JJ Janus) (JJ kinase)
          (PRN (-LRB- -LRB-)
            (NP (NNP JAK))
            (-RRB- -RRB-))
          (NN family) (NN tyrosine) (NN kinases) (NNS Jak1)
          (CC and)
          (NNS Tyk2))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP are)
              (ADVP (RB constitutively))
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (NN IL-10R1)
                      (CC and)
                      (NN type))
                    (ADJP (CD 2) (JJ IL-10R))))
                (, ,)
                (S
                  (ADVP (RB respectively))
                  (VP (VBG -LSB-)
                    (NP (CD 2) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-10))
    (VP (VBZ induces)
      (NP
        (NP (JJ tyrosine) (NN phosphorylation)
          (CC and)
          (NN activation))
        (PP (IN of)
          (NP (DT the)
            (ADJP (JJ latent) (JJ transcriptional))
            (NNS factors) (NN signal) (NN transducer)
            (CC and)
            (NN activator)))
        (PP (IN of)
          (NP
            (NP
              (NP (NN transcription))
              (PRN (-LRB- -LRB-)
                (NP (NNP STAT))
                (-RRB- -RRB-)))
            (NP
              (QP (CD 3)
                (CC and)
                (CD STAT1) (CD -LSB-) (CD 3))
              (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN Upon)
      (NP (NN phosphorylation)))
    (, ,)
    (NP (NNP STAT1)
      (CC and)
      (NNP STAT3) (NNS proteins))
    (VP
      (VP (VBP form)
        (NP (NNS homodimers)
          (CC or)
          (NNS heterodimers)))
      (, ,)
      (VP
        (ADJP (RB rapidly) (JJ translocate))
        (PP (IN into)
          (NP (DT the) (NN nucleus))))
      (, ,)
      (CC and)
      (VP (VBP modulate)
        (NP (NN gene) (NN transcription))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Intriguingly))
    (, ,)
    (NP (NNP STAT3))
    (VP (VBZ is)
      (ADJP (JJ indispensable)
        (PP (IN for)
          (NP
            (NP (DT both) (NN IL-10-derived) (NN anti-inflammatory))
            (CC and)
            (NP (NN IL-6-derived) (NN proinflammatory) (NNS responses)))))
      (S
        (VP (VBG -LSB-)
          (NP (CD 4) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Studies))
      (PP (IN of)
        (NP (JJ cell-type-specific) (NN STAT3-deficient) (NNS mice))))
    (VP
      (VP (VBP have)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (NNP STAT3) (NNP activation))
              (VP (VBZ is)
                (ADJP (JJ essential)
                  (PP (IN for)
                    (NP
                      (NP (JJ IL-10-mediated) (JJ anti-inflammatory) (NNS reactions))
                      (PP (IN in)
                        (NP (NNS macrophages)
                          (CC and)
                          (NNS neutrophils))))))
                (S
                  (VP (VBG -LSB-)
                    (NP (CD 5) (NNS -RSB-)))))))))
      (, ,)
      (CC but)
      (VP (VBZ is)
        (ADJP (JJ responsible)
          (PP (IN for)
            (NP
              (NP (NN IL-6-mediated) (NN prevention))
              (PP (IN of)
                (NP
                  (NP (NNS apoptosis))
                  (PP (IN in)
                    (NP (NNP T) (NNS cells)))))
              (VP (VBG -LSB-)
                (NP (CD 6) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN suppressor))
        (PP (IN of)
          (NP
            (ADJP (JJ cytokine) (JJ signaling))
            (PRN (-LRB- -LRB-)
              (NP (NNP SOCS))
              (-RRB- -RRB-))
            (NNS proteins))))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN identified)
            (PP (IN as)
              (NP
                (NP (DT a) (NN family))
                (PP (IN of)
                  (NP
                    (NP (JJ endogenous) (NNP JAK) (NN kinase) (NNS inhibitors))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (MD can)
                          (VP (VB act)
                            (PP (IN in)
                              (NP (JJ classic) (NN feedback) (NN inhibition) (NNS loops)))))))))))))))
    (, ,)
    (CC but)
    (S
      (NP
        (NP (PRP$ their) (NNS roles))
        (PP (IN as)
          (NP
            (NP (DT the) (NNS mediators))
            (PP (IN of)
              (NP
                (NP (NN crosstalk) (NN inhibition))
                (PP (IN by)
                  (S
                    (VP (VBG opposing)
                      (NP (NN cytokine))
                      (S
                        (VP (VBG signaling)
                          (NP (NNS pathways))))))))))))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN clarified)
            (NP
              (QP (CD -LSB-) (CD 7))
              (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP (NNP SOCS3))
          (VP (VBZ plays)
            (NP (DT a) (JJ key) (NN role))
            (PP (IN in)
              (S
                (VP (VBG regulating)
                  (NP
                    (NP (DT the) (JJ divergent) (NN action))
                    (PP (IN of)
                      (NP (NN IL-10)
                        (CC and)
                        (NN IL-6)))))))
            (, ,)
            (PP (IN by)
              (S
                (ADVP (RB specifically))
                (VP (VBG blocking)
                  (NP
                    (NP
                      (NP (JJ STAT3) (NN activation))
                      (VP (VBN induced)
                        (PP (IN by)
                          (NP (NN IL-6)))))
                    (CONJP (CC but)
                      (RB not))
                    (NP
                      (NP (DT that))
                      (VP (VBN induced)
                        (PP (IN by)
                          (NP (NNP IL-10) (NNP -LSB-) (CD 8,9) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (JJ synovial) (NN membrane))
        (PP (IN of)
          (NP (JJ rheumatoid) (NN arthritis))))
      (PRN (-LRB- -LRB-)
        (NP (NNP RA))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (VP (VBN characterized)
        (PP (IN by)
          (NP
            (NP (DT an) (NN infiltrate))
            (PP (IN of)
              (NP
                (NP (DT a) (NN variety))
                (PP (IN of)
                  (NP (JJ inflammatory) (NNS cells)))
                (, ,)
                (PP (JJ such) (IN as)
                  (NP
                    (NP (NNS lymphocytes))
                    (, ,)
                    (NP (NNS macrophages))
                    (, ,)
                    (CC and)
                    (NP (JJ dendritic) (NNS cells)))))))
          (, ,)
          (ADVP (RB together)))
        (PP (IN with)
          (NP
            (NP (NN proliferation))
            (PP (IN of)
              (NP (JJ synovial) (JJ fibroblast-like) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Numerous) (NNS cytokines))
      (VP (VBP are)
        (VP (VBN overproduced)
          (PP (IN in)
            (NP (DT the) (JJ inflamed) (NN joint))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (NNS macrophages))
        (CC and)
        (NP (JJ synovial) (NNS fibroblasts)))
      (VP (VBP are)
        (NP
          (NP (DT an) (JJ important) (NN source))
          (PP (IN of)
            (NP (JJ proinflammatory) (NNS cytokines))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Tumor))
      (VP (VBZ necrosis)
        (SBAR
          (S
            (NP
              (NP
                (NP (NN factor) (NNS alpha))
                (PRN (-LRB- -LRB-)
                  (NP (NNP TNF-α))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (NP (NN IL-1))
                (, ,)
                (NP (CD two) (JJ major) (NN macrophage) (NNS products))
                (, ,)))
            (VP (VBP are)
              (ADJP (JJ crucial)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN process))
                    (PP (IN of)
                      (NP
                        (NP (JJ chronic) (NN inflammation))
                        (CC and)
                        (NP (JJ joint) (NN destruction))))))))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP they))
      (VP (VBP give)
        (NP (NN rise))
        (PP (TO to)
          (NP (NN effector) (NNS components)))
        (, ,)
        (PP (VBG including)
          (NP
            (NP (JJ other) (JJ inflammatory) (NNS cytokines))
            (, ,)
            (NP (NNS chemokines))
            (, ,)
            (NP (NN growth) (NNS factors))
            (, ,)
            (NP (NN matrix) (NNS proteases))
            (, ,)
            (NP (JJ nitric) (NN oxide))
            (, ,)
            (CC and)
            (NP
              (NP (JJ reactive) (NN oxygen) (NNS species))
              (NP
                (QP (CD -LSB-) (CD 10))
                (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP IL-6))
      (VP (VBZ is)
        (NP
          (NP (DT a) (JJ pleiotropic) (NN cytokine))
          (VP (VBN produced)
            (ADVP (RB substantially))
            (PP (IN by)
              (NP (VBN activated) (NNS fibroblasts)))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP$ its) (JJ proinflammatory) (NNS actions))
      (VP (VBP include)
        (S
          (VP (VBG simulating)
            (NP
              (NP (DT the) (JJ acute-phase) (NN response))
              (, ,)
              (NP
                (NP (JJ B-cell) (NN maturation))
                (PP (IN into)
                  (NP (NN plasma) (NNS cells))))
              (, ,)
              (NP (JJ T-cell) (NNS functions))
              (, ,)
              (CC and)
              (NP
                (NP (JJ hematopoietic) (NN precursor) (NN cell) (NN differentiation))
                (VP (VBG -LSB-)
                  (NP (CD 11) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ anti-inflammatory) (NNS cytokines)
      (CC and)
      (NN cytokine) (NNS inhibitors))
    (VP (VBP are)
      (ADVP (RB also))
      (ADJP (JJ present)
        (PP (IN in)
          (NP
            (NP (JJ large) (NNS quantities))
            (PP (IN in)
              (NP (NNP RA) (NNS joints)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NN IL-10))
        (, ,)
        (VP (VBN produced)
          (PP
            (PP (IN by)
              (NP (NNS macrophages)))
            (CC and)
            (RB partly)
            (PP (IN by)
              (NP (NNP T) (NNS cells))))
          (PP (IN in)
            (NP
              (NP (DT the) (JJ synovial) (NN tissue))
              (PRN (-LRB- -LRB-)
                (NP (NNP ST))
                (-RRB- -RRB-)))))
        (, ,))
      (VP (VBZ is)
        (VP (RBS best) (VBN known)
          (PP (IN as)
            (NP
              (NP (DT a) (JJ negative) (NN regulator))
              (PP (IN for)
                (NP (JJ macrophage)
                  (CC and)
                  (JJ Th1) (NNS cells))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT the) (NN expression) (NN level))
      (VP (VBZ is)
        (ADJP (JJ insufficient)
          (S
            (VP (TO to)
              (VP (VB counterbalance)
                (NP
                  (NP (DT the) (NN cascade))
                  (PP (IN of)
                    (NP (JJ proinflammatory) (NNS events))))
                (S
                  (VP (VBG -LSB-)
                    (NP (CD 12) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (DT the) (JJ anti-inflammatory) (NN action))
      (PP (IN of)
        (NP (NN IL-10))))
    (VP (VBZ appears)
      (S
        (VP (TO to)
          (VP (VB be)
            (VP (VBN modulated)
              (PP (IN at)
                (NP
                  (NP (DT the) (NN level))
                  (PP (IN of)
                    (NP (NN signal) (NN transduction)))))
              (PP (IN during)
                (NP (JJ chronic) (NN inflammation))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-10) (NNP signaling))
    (VP (VBZ is)
      (VP (VBN impaired)
        (PP (IN in)
          (NP (NNS macrophages)))
        (PP (IN upon)
          (NP (JJ chronic) (NN exposure)))
        (PP (TO to)
          (NP
            (NP
              (NP (JJ proinflammatory) (NNS cytokines))
              (PP (JJ such) (IN as)
                (NP (NNP TNF-α)
                  (CC and)
                  (NNP IL-1))))
            (CC and)
            (NP
              (NP (JJ immune) (NNS complexes))
              (NP
                (QP (CD -LSB-) (CD 13,14))
                (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (JJ Cell) (NN surface) (NN expression))
        (PP (IN of)
          (NP (NN IL-10R1))))
      (VP (VBZ is)
        (VP (VBN decreased)
          (PP (IN in)
            (NP
              (NP (JJ synovial) (JJ fluid) (JJ dendritic) (NNS cells))
              (ADJP (JJ due)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN presence))
                    (PP (IN of)
                      (NP (NNP TNF-α) (, ,) (NNP IL-1) (, ,)
                        (CC and)
                        (NNP granulocyte)))))))))))
    (: --)
    (S
      (NP (JJ macrophage) (JJ colony-stimulating) (NN factor))
      (VP (VBZ -LSB-)
        (NP (CD 15) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP (MD may)
      (VP (VB be)
        (VP (VBN activated)
          (PP (IN by)
            (NP (JJ arthritogenic) (NNS antigens)))
          (, ,)
          (PP (IN in)
            (NP
              (NP (NN conjunction))
              (PP (IN with)
                (NP
                  (NP (NNS CD28-mediated))
                  (VP
                    (ADVP (RB costimulatory))
                    (VBG signaling) (, ,)
                    (PP (IN in)
                      (NP (NNP RA)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN significance))
        (PP (IN of)
          (NP (DT this) (JJ autoimmune) (NN process))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN supported)
            (PP (IN by)
              (NP
                (NP (DT the) (NN linkage))
                (PP (IN of)
                  (NP (DT the) (NNP MHC) (NN class)))))))))
    (NP (NNP II))
    (VP (VBZ antigens)
      (NP
        (NP (NNP HLA-DRB1) (NNP *) (NNP 0404)
          (CC and)
          (NNP HLA-DRB1) (NNP *) (CD 0401))
        (PP
          (PP (IN with)
            (NP
              (NP (NN disease) (NN susceptibility)
                (CC and)
                (NN severity))
              (VP (VBG -LSB-)
                (NP (CD 16,17) (NNS -RSB-)))))
          (, ,)
          (CC and)
          (PP (IN by)
            (NP
              (NP
                (NP (DT the) (JJ high-level) (NN expression))
                (PP (IN of)
                  (NP (NNP MHC) (NN class) (NNP II) (NNP molecules))))
              (CC and)
              (NP
                (NP
                  (NP (DT both) (CD CD28) (NNS ligands))
                  (, ,)
                  (NP (NNP CD80)
                    (CC and)
                    (NNP CD86))
                  (, ,))
                (PP (IN in)
                  (NP (DT the) (JJ inflamed) (NNP ST) (NNP -LSB-) (JJ 18-20) (NN -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (VBG continuing) (NN emergence))
        (PP (IN of)
          (NP (VBN activated) (NNP CD4) (NNP +) (NNP T) (NNS cells))))
      (, ,) (RB even)
      (NP
        (NP (IN though) (JJ few))
        (PP (IN in)
          (NP (NN number))))
      (, ,))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ crucial)
          (PP (IN in)
            (S
              (VP (VBG sustaining)
                (NP
                  (NP (DT the) (NN activation))
                  (PP (IN of)
                    (NP
                      (NP (NNS macrophages))
                      (CC and)
                      (NP (JJ synovial) (NNS fibroblasts)))))
                (PP (IN through)
                  (NP
                    (NP (NN cell) (NN surface))
                    (VP (VBG signaling)
                      (PP (IN by)
                        (NP
                          (NP
                            (NP (NNS means))
                            (PP (IN of)
                              (NP
                                (NP (NN cell) (NN surface) (NN CD69))
                                (CC and)
                                (NP (NNP CD11)))))
                          (, ,)
                          (CONJP (RB as) (RB well) (IN as))
                          (NP
                            (NP (DT the) (NN release))
                            (PP (IN of)
                              (NP
                                (NP (JJ proinflammatory) (JJ Th1) (NNS cytokines))
                                (PP (JJ such) (IN as)
                                  (NP
                                    (NP (NN interferon) (NN gamma))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NNP IFN))
                                      (-RRB- -RRB-)))))))
                          (: -)
                          (NP (NN γ))
                          (CC and)
                          (NP (NNP IL-17) (NNP -LSB-) (CD 21,22) (NNP -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP (MD could)
      (VP (VB stimulate)
        (NP
          (NP (JJ B-cell) (NN production))
          (PP (IN of)
            (NP
              (NP (NNS autoantibodies))
              (PP (JJ such) (IN as)
                (NP
                  (NP (JJ rheumatoid) (NN factor))
                  (CC and)
                  (NP (JJ osteoclast-mediated) (NN bone) (NN destruction)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (PRP$ Their) (JJ obligatory) (NN role))
      (PP (IN in)
        (NP (NNP RA) (NNS synovitis))))
    (VP (VBD was)
      (ADVP (RB recently))
      (VP (VBN proved)
        (PP (IN by)
          (NP
            (NP (JJ successful) (NN treatment))
            (PP (IN of)
              (NP (JJ active) (NN disease)))))
        (PP (IN by)
          (NP
            (NP (JJ selective) (NN inhibition))
            (PP (IN of)
              (NP (JJ T-cell) (NN activation)))))
        (PP (IN with)
          (NP
            (NP (NN fusion) (NN protein))
            (PP (IN of)
              (NP
                (NP (JJ cytotoxic) (JJ T-cell-associated) (NN antigen) (CD 4))
                (PRN (-LRB- -LRB-)
                  (NP (NNP CD152))
                  (-RRB- -RRB-))))))
        (: -)
        (NP
          (NP (NNP IgG))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (MD can)
                (VP (VB block)
                  (NP
                    (NP (DT the) (NN engagement))
                    (PP (IN of)
                      (NP (NNP CD28))))
                  (PP (IN on)
                    (NP (NNP T) (NNS cells)))
                  (PP (IN by)
                    (NP
                      (ADJP (JJ binding)
                        (PP (TO to)
                          (NP (NNP CD80)
                            (CC and)
                            (NNP CD86)))
                        (PP (IN with)
                          (ADJP (JJ high))))
                      (JJ avidity) (JJ -LSB-) (CD 23) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-10) (NNP efficiently))
    (VP (VBZ blocks)
      (NP (DT the) (JJ antigen-specific) (NNP T-cell) (NN cytokine) (NN response))
      (PP
        (PP (IN by)
          (S
            (VP (VBG inhibiting)
              (NP
                (NP (DT the) (NN CD28))
                (VP (VBG signaling)
                  (ADVP (RB pathway))
                  (NP
                    (QP (CD -LSB-) (CD 24))
                    (NNS -RSB-)))))))
        (, ,)
        (CONJP (RB as) (RB well) (IN as))
        (PP
          (ADVP (RB indirectly))
          (IN by)
          (S
            (VP (VBG downregulating)
              (NP
                (NP (DT the) (NN function))
                (PP (IN of)
                  (NP (JJ antigen-presenting) (NNS cells)))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB elucidate)
          (NP
            (NP (DT the) (NN resistance))
            (PP (IN of)
              (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
          (PP (TO to)
            (NP
              (NP (DT this) (JJ direct) (NN inhibition))
              (PP (IN in)
                (NP (NNP RA))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN production))
        (PP (IN of)
          (NP
            (NP
              (ADJP (JJ IFN-γ)
                (PP (IN after)
                  (NP (NNP CD3)
                    (CC and)
                    (NNP CD28))))
              (ADJP (JJ costimulation)
                (PP
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN presence))
                      (PP (IN of)
                        (NP
                          (NP (NN IL-10))
                          (, ,)
                          (NP
                            (NP (DT the) (NN induction))
                            (PP (IN of)
                              (NP (NNP STAT1)
                                (CC and)
                                (NNP STAT3)))
                            (VP (VBN phosphorylation)
                              (PP (IN by)
                                (NP (NN IL-10)))))))))
                  (, ,)
                  (CC and)
                  (PP
                    (NP
                      (NP (DT the) (NN expression))
                      (PP (IN of)
                        (NP (NNP SOCS1)
                          (CC and)
                          (NNP SOCS3) (NNP mRNA))))
                    (IN in)
                    (NP
                      (NP (JJ peripheral) (NN blood))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP PB))
                        (-RRB- -RRB-))))))
              (JJ CD4) (JJ +) (NN T) (NNS cells))
            (PP (IN from)
              (NP (NNP RA) (NNS patients)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Materials)
        (CC and)
        (NNS methods))
      (SBAR
        (S
          (NP (DT The) (JJ total) (NN patient) (NN population))
          (VP (VBD consisted)
            (PP (IN of)
              (NP (CD 32) (NNS patients)))
            (PP (IN with)
              (NP (NNP RA))))))
      (PRN (-LRB- -LRB-)
        (NP
          (NP
            (NP
              (NP (CD 25) (NNS women))
              (CC and)
              (NP (CD seven) (NNS men)))
            (: ;)
            (NP
              (NP (JJ mean) (JJ ±) (JJ standard) (NN deviation) (NN age))
              (, ,)
              (NP (CD 52.8) (NNS ±))))
          (NP (CD 12.4) (NNS years)))
        (-RRB- -RRB-)))
    (VP (VBD diagnosed)
      (PP (VBG according)
        (PP (TO to)
          (NP
            (NP (DT the) (JJ revised) (CD 1987) (NNS criteria))
            (PP (IN of)
              (NP
                (NP (DT the) (NNP American) (NNP College))
                (PP (IN of)
                  (NP (JJ Rheumatology)
                    (PRN (-LRB- -LRB-)
                      (ADVP (RB formally))
                      (, ,)
                      (NP (DT the) (NNP American) (NNP Rheumatism) (NNP Association))
                      (-RRB- -RRB-))
                    (JJ -LSB-) (CD 25) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT All) (NNS patients))
    (VP (VBD were)
      (VP
        (VP (VBG receiving)
          (NP (NN prednisolone)))
        (PRN (-LRB- -LRB-)
          (S
            (VP (VBG ≤)
              (NP (CD 7.5))
              (ADVP (RB mg/day))))
          (-RRB- -RRB-))
        (CC and)
        (VP (VBG disease-modifying)
          (NP (JJ antirheumatic) (NNS drugs)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Clinical) (NNS parameters))
      (PP (IN in)
        (NP (DT the) (NN study) (NNS patients))))
    (VP (VBD were)
      (NP
        (SBAR (IN as)
          (S
            (VP
              (VP (VBZ follows))
              (PRN (-LRB- -LRB-)
                (S
                  (VP (VB mean)
                    (NP (JJ ±) (JJ standard) (NN deviation))))
                (-RRB- -RRB-)))))
        (: :)
        (NP
          (NP
            (NP (JJ erythrocyte) (NN sedimentation) (NN rate))
            (, ,)
            (NP
              (QP (CD 55.9) (CD ±))
              (VBN 35.4) (NN mm/hour)))
          (: ;)
          (NP
            (NP (NN serum) (JJ C-reactive) (NN protein))
            (PRN (-LRB- -LRB-)
              (NP (NNP CRP))
              (-RRB- -RRB-))
            (NP (NN level)))
          (, ,)
          (NP
            (NP
              (QP (CD 32.0) (CD ±)))
            (NP (CD 32.0) (NN mg/l)))
          (: ;)
          (CC and)
          (NP
            (NP (NNP IgM) (NNP class) (JJ rheumatoid) (NN factor) (NN titer))
            (, ,)
            (NP (CD 142) (NNP ±) (CD 158) (NNP U/ml))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNS Patients))
      (VP (VBD were)
        (VP (VBN divided)
          (PP (IN into)
            (NP (CD two) (NNS groups))))))
    (: :)
    (S
      (NP
        (NP (CD 24) (NNS patients))
        (PP (IN with)
          (NP
            (NP (JJ active) (NN disease))
            (, ,)
            (SBAR
              (WHNP (WP who))
              (S
                (VP (VBD had)
                  (NP
                    (NP
                      (NP (JJ multiple) (NN tender) (NN and/or))
                      (NP (JJ swollen) (NNS joints)))
                    (CC and)
                    (NP
                      (NP (JJ elevated) (NN serum))
                      (NP
                        (NP (NNP CRP) (NN level))
                        (PRN (-LRB- -LRB-)
                          (ADJP
                            (NP (NNP ≥) (CD 10))
                            (JJ mg/l))
                          (-RRB- -RRB-))))
                    (: ;)
                    (CC and)
                    (NP (CD eight) (NNS patients)))
                  (PP (IN with)
                    (NP
                      (NP (JJ inactive) (NN disease))
                      (, ,)
                      (SBAR
                        (WHNP (WP who))
                        (S
                          (VP (VBD satisfied)
                            (NP
                              (NP (DT the) (NNP American) (NNP College))
                              (PP (IN of)
                                (NP (NNP Rheumatology) (JJ preliminary) (NNS criteria))))
                            (PP (IN for)
                              (NP (JJ clinical) (NN remission))))))))))))))
      (VP (VBZ -LSB-)
        (NP (CD 26) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Sixteen) (JJ healthy) (NNS volunteers))
      (PRN (-LRB- -LRB-)
        (NP
          (NP
            (NP
              (NP (CD 11) (NNS women))
              (CC and)
              (NP (CD five) (NNS men)))
            (: ;)
            (NP
              (NP (NN age))
              (, ,)
              (NP (CD 45.8) (NNS ±))))
          (NP (CD 11.2) (NNS years)))
        (-RRB- -RRB-)))
    (VP (VBD served)
      (PP (IN as)
        (NP (NNS controls))))
    (. .)))

(ROOT
  (S
    (NP (NNP ST) (NNS samples))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN from)
          (NP (CD three) (NNP RA) (NNS patients)))
        (S
          (VP (VBG undergoing)
            (NP (JJ total) (NN knee) (NN replacement))))))
    (. .)))

(ROOT
  (S
    (NP (DT All) (NNS patients))
    (VP (VBD gave)
      (NP (VBN informed) (NN consent)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Peripheral) (NN blood) (NN mononuclear) (NNS cells))
      (PRN (-LRB- -LRB-)
        (NP (NNP PBMC))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN prepared)
        (PP (IN from)
          (NP (JJ heparinized) (NN blood) (NNS samples)))
        (PP (IN by)
          (NP
            (NP (NN centrifugation))
            (PP (IN over)
              (NP
                (NP (JJ Ficoll-Hypaque) (NN density) (NNS gradients))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Pharmacia))
                  (, ,)
                  (NP (NNP Uppsala))
                  (, ,)
                  (NP (NNP Sweden))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP (VBD were)
      (VP (VBN purified)
        (PP (IN from)
          (NP (NNP PBMC)))
        (PP (IN by)
          (NP (JJ positive) (NN selection)))
        (S
          (VP (VBG using)
            (NP
              (NP (JJ anti-CD4) (JJ mAb-coated) (JJ magnetic) (NNS beads))
              (PRN (-LRB- -LRB-)
                (NP (NNP Miltenyi) (NNP Biotec))
                (, ,)
                (NP (NNP Gladbach))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-)))))
        (, ,)
        (PP (VBG according)
          (PP (TO to)
            (NP
              (NP (DT the) (NN manufacturer) (POS 's))
              (NNS instructions))))))
    (. .)))

(ROOT
  (S
    (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP (VBD were)
      (VP (VBN isolated)
        (PP (IN from)
          (NP
            (NP (NNP ST) (NNS samples))
            (, ,)
            (SBAR (IN as)
              (S
                (ADVP (RB previously))
                (VP (VBD described)
                  (NP
                    (QP (CD -LSB-) (CD 27))
                    (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Briefly))
    (, ,)
    (NP (JJ fresh) (NNP ST) (NNS samples))
    (VP (VBD were)
      (VP (VBN fragmented)
        (CC and)
        (VBN digested)
        (PP (IN with)
          (NP
            (NP (NN collagenase)
              (CC and)
              (NN DNase))
            (PP (IN for)
              (NP
                (NP (CD 1) (NN hour))
                (PP (IN at)
                  (NP (CD 37) (NN °) (NNP C)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG removing)
          (NP (NN tissue) (NN debris)))))
    (, ,)
    (NP
      (NP (NNP ST) (NN cell) (NNS suspensions))
      (PP (IN in)
        (NP
          (NP (NN culture) (NN medium))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP RPMI) (CD 1640) (NN medium))
              (: ;)
              (NP (NNP Life) (NNP Technologies) (, ,) (NNP Gaithersburg) (, ,) (NNP MD) (, ,) (NNP USA)))
            (-RRB- -RRB-))
          (VP (VBN supplemented)
            (PP (IN with)
              (NP
                (NP
                  (NP (CD 25) (NN mM) (NNS HEPES))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 2) (NN mM) (NN L-glutamine))
                      (, ,)
                      (NP
                        (NP
                          (ADJP (CD 2) (NN %))
                          (JJ nonessential) (JJ amino) (NNS acids))
                        (, ,)
                        (NP (CD 100) (JJ IU/ml) (NN penicillin)))
                      (, ,)
                      (CC and)
                      (NP
                        (NP (CD 100) (JJ mg/ml) (NN streptomycin))
                        (: ;)
                        (NP (NNP Life) (NNPS Technologies))))
                    (-RRB- -RRB-)))
                (PP (IN with)
                  (NP
                    (NP
                      (ADJP (CD 10) (NN %))
                      (JJ heat-inactivated) (NN FCS))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Life) (NNP Technologies))
                      (-RRB- -RRB-))))))))))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN at)
          (NP
            (NP (CD 37) (NNP °) (NNP C))
            (PP (IN in)
              (NP
                (NP
                  (NP (JJ six-well) (NNS plates))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Coster))
                    (, ,)
                    (NP (NNP Cambridge))
                    (, ,)
                    (NP (NNP MA) (, ,) (NNP USA))
                    (-RRB- -RRB-)))
                (PP (IN for)
                  (NP (CD 45) (NN min)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Non-adherent) (NNS cells))
      (VP (VBD were)
        (VP (VBN harvested))))
    (CC and)
    (S
      (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
      (VP (VBD were)
        (VP (VBN purified)
          (PP (IN by)
            (NP (JJ positive) (NN selection))))))
    (SBAR (IN as)
      (S
        (ADVP (RB already))
        (VP (VBD described))))
    (. .)))

(ROOT
  (FRAG
    (NP
      (NP (NNP PB) (NNP CD4) (NNP +) (NNP T-cell))
      (SBAR
        (S
          (NP (NNS populations))
          (VP (VBD were)
            (VP (VBN resuspended)
              (PP (IN at)
                (NP
                  (NP (DT a) (NN density))
                  (PP (IN of)
                    (NP
                      (NP (CD 1)
                        (ADJP
                          (QP (CD ×) (CD 106)))
                        (JJ cells/ml)
                        (UCP
                          (PP (IN in)
                            (NP
                              (NP (NN culture) (NN medium))
                              (PP (IN with)
                                (NP
                                  (ADJP (CD 10) (NN %))
                                  (NNP FCS)))))
                          (, ,)
                          (CC and)
                          (NP (CD 0.5)))
                        (JJ ml) (NN cell) (NNS suspensions))
                      (SBAR
                        (S
                          (VP (VBD were)
                            (VP (VBN dispensed)
                              (PP (IN into)
                                (NP
                                  (NP (DT the) (NNS wells))
                                  (PP (IN of)
                                    (NP
                                      (NP (JJ 24-well) (NN microtiter) (NNS plates))
                                      (PRN (-LRB- -LRB-)
                                        (NP (NNP Coster))
                                        (-RRB- -RRB-))
                                      (VP (VBN coated)
                                        (PP (IN with)
                                          (NP (CD 1) (NN μg)))))))))))))))))))))
    (: /)
    (VP (VBP ml)
      (NP
        (NP (JJ anti-CD3) (NN mAb))
        (PRN (-LRB- -LRB-)
          (NP (NNP Immunotech))
          (, ,)
          (NP (NNP Marseille))
          (, ,)
          (NP (NNP France))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS cells))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP (CD 1) (NN μg)
              (PRN (: /)
                (NP
                  (NP
                    (NP (NN ml) (JJ anti-CD28) (NN mAb))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Immunotech))
                      (-RRB- -RRB-)))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN presence)
                        (CC or)
                        (NN absence))
                      (PP (IN of)
                        (NP
                          (NP (DT the) (JJ indicated) (NNS concentrations))
                          (PP (IN of)
                            (NP (NN IL-10))))))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP Becton) (NNP Dickinson))
              (, ,)
              (NP (NNP San) (NNP Jose))
              (, ,)
              (NP (NNP CA) (, ,) (NNP USA))
              (-RRB- -RRB-))))
        (PP (IN at)
          (NP
            (NP (CD 37) (NNP °) (NNP C))
            (PP (IN in)
              (NP
                (NP (DT a) (JJ humidified) (NN atmosphere))
                (VP (VBG containing)
                  (NP
                    (ADJP (CD 5) (NN %))
                    (JJ CO2)
                    (QP (CD -LSB-) (CD 28))
                    (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Culture) (NNS supernatants))
      (VP (VBD were)
        (VP (VBN collected)
          (NP (CD 36) (NNS hours) (RB later)))))
    (CC and)
    (S
      (NP (JJ cell-free) (NNS samples))
      (VP (VBD were)
        (VP (VBN stored)
          (PP (IN at)
            (NP (NNP -30) (NNP °) (NNP C)))
          (PP (IN until)
            (NP (JJ cytokine) (NN assay))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB examine)
          (NP
            (NP (DT the) (NN effect))
            (PP (IN of)
              (NP (NN IL-6))))
          (PP (IN on)
            (NP (JJ T-cell) (NNS responsiveness)))
          (PP (TO to)
            (NP (NN IL-10))))))
    (, ,)
    (NP
      (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
      (PP (IN from)
        (NP (JJ healthy) (NNS controls))))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN in)
          (NP
            (NP (NN culture) (NN medium))
            (PP (IN with)
              (NP
                (ADJP (CD 10) (NN %))
                (NNP FCS)))))
        (PP (IN in)
          (NP
            (NP (DT the) (NN presence)
              (CC or)
              (NN absence))
            (PP (IN of)
              (NP
                (NP
                  (NP (CD 10) (JJ ng/ml) (NN IL-6))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Becton) (NNP Dickinson))
                    (-RRB- -RRB-)))
                (PP (IN for)
                  (NP (CD 36) (NNS hours)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Cells))
    (VP (VBD were)
      (ADVP (RB then))
      (VP (VBN stimulated)
        (PP (IN for)
          (NP
            (NP
              (NP (CD 36) (NNS hours))
              (PP (IN with)
                (NP (JJ anti-CD3) (NN mAb))))
            (CC and)
            (NP
              (NP (JJ anti-CD28) (NN mAb))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN presence)
                    (CC or)
                    (NN absence))
                  (PP (IN of)
                    (NP (CD 1) (JJ ng/ml) (NN IL-10))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Culture) (NNS supernatants))
    (VP (VBD were)
      (VP (VBN measured)
        (PP (IN for)
          (NP (JJ IFN-γ) (NNS concentrations)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (NN sample))
      (PP (IN of)
        (NP
          (NP (CD 5) (JJ ×) (CD 105) (NNS cells))
          (PP (IN of)
            (NP (NNP PBMC))))))
    (VP (VBD was)
      (VP (VBN resuspended)
        (PP (IN in)
          (NP (NNP PBS)))
        (PP (IN with)
          (NP
            (ADJP (CD 1) (NN %))
            (NNP FCS)))))
    (. .)))

(ROOT
  (S
    (NP (NNP PBMC))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP
          (PP (IN with)
            (NP
              (NP (VBG saturating) (NNS concentrations))
              (PP (IN of)
                (NP
                  (NP (JJ anti-IL-10R1) (NN mAb))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNS IgG1))
                      (: ;)
                      (NP (NNP R&D) (NNS systems)))
                    (, ,)
                    (NP
                      (NP (NNP Minneapolis))
                      (, ,)
                      (NP (NNP MN) (, ,) (NNP USA)))
                    (-RRB- -RRB-))))))
          (CC or)
          (PP (IN with)
            (NP
              (NP
                (NP (JJ isotype-matched) (NN control) (NN mAb))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Immunotech))
                  (-RRB- -RRB-)))
              (, ,)
              (VP (VBN followed)
                (PP (IN by)
                  (NP
                    (NP
                      (ADJP (JJ incubation)
                        (PP (IN with)
                          (NP (JJ FITC-conjugated) (NN goat) (NN anti-mouse) (NNS IgG1))))
                      (JJ polyclonal) (NN antibody))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Santa) (NNP Cruz) (NNP Biotechnologies))
                      (, ,)
                      (NP (NNP Santa) (NNP Cruz))
                      (, ,)
                      (NP (NNP CA) (, ,) (NNP USA))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Cells))
    (VP (VBD were)
      (ADVP (RB then))
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP (JJ phycoerythrin-conjugated) (JJ anti-CD4) (NN mAb))
            (PRN (-LRB- -LRB-)
              (NP (NNP Becton) (NNP Dickinson))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Cells))
    (VP (VBD were)
      (VP (VBN washed)
        (ADVP (RB well))
        (PP (IN with)
          (NP
            (NP
              (ADJP (CD 1) (NN %))
              (NNS FCS/PBS))
            (PP (IN between)
              (NP (NNS incubations)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Analysis))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN on)
          (NP
            (NP (DT a) (NNP FACScan) (NN flow) (NN cytometer))
            (PRN (-LRB- -LRB-)
              (NP (NNP Becton) (NNP Dickinson))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Concentrations))
      (PP (IN of)
        (NP (NNP IFN-γ)
          (CC and)
          (NNP IL-2)))
      (PP (IN in)
        (NP
          (NP (NN culture) (NNS supernatants))
          (PP (IN of)
            (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))))
    (VP (VBD were)
      (VP (VBN measured)
        (PP (IN in)
          (NP (NNP duplicate)))
        (PP (IN by)
          (NP (DT the) (JJ quantitative) (NN sandwich) (NN ELISA)))
        (S
          (VP (VBG using)
            (NP (JJ cytokine-specific) (NN capture))
            (PP (IN with)
              (NP (JJ biotinylated) (NN detection) (NN mAb)
                (CC and)
                (JJ recombinant) (NN cytokine) (NNS proteins)))
            (PRN (-LRB- -LRB-)
              (PP
                (ADVP (DT all))
                (IN from)
                (NP (NNP Becton) (NNP Dickinson)))
              (-RRB- -RRB-))))
        (, ,)
        (PP (VBG according)
          (PP (TO to)
            (NP
              (NP (DT the) (NN manufacturer) (POS 's))
              (NN protocol))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN detection) (NNS limits))
      (PP (IN for)
        (NP (NNP IFN-γ)
          (CC and)
          (NNP IL-2))))
    (VP (VBD were)
      (ADJP
        (NP (CD 15))
        (JJ pg/ml)))
    (. .)))

(ROOT
  (S
    (NP (JJ Total) (JJ cellular) (NNS RNA))
    (VP (VBD was)
      (VP (VBN extracted)
        (PP (IN from)
          (NP (NNP PB) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
        (S
          (VP (VBG using)
            (NP
              (NP (DT an) (NNP RNA) (NN isolation) (NN kit))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP RNeasy) (NNP Mini) (NNP kit))
                  (: ;)
                  (NP (NNP Qiagen) (, ,) (NNP Valencia) (, ,) (NNP CA) (, ,) (NNP USA)))
                (-RRB- -RRB-)))))
        (, ,)
        (PP (VBG according)
          (PP (TO to)
            (NP
              (NP (DT the) (NN manufacturer) (POS 's))
              (NNS instructions))))))
    (. .)))

(ROOT
  (S
    (NP (NN cDNA))
    (VP (VBD was)
      (VP (VBN synthesized)
        (PP (IN from)
          (NP (JJ total) (NNP RNA)))
        (PP (IN with)
          (NP
            (NP
              (NP (NNP Molony) (NN murine) (NN leukemia) (NN virus))
              (NP
                (NP (JJ reverse) (NN transcriptase))
                (PRN (-LRB- -LRB-)
                  (NP (NNP US) (NNP Biochemical))
                  (, ,)
                  (NP (NNP Cleveland))
                  (, ,)
                  (NP (NNP OH) (, ,) (NNP USA))
                  (-RRB- -RRB-))))
            (CC and)
            (NP
              (NP (NN oligo))
              (: -)
              (NP
                (NP (-LRB- -LRB-) (NN dT) (-RRB- -RRB-))
                (NP
                  (NP (CD 15) (NNS primers))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Promega))
                    (, ,)
                    (NP (NNP Madison))
                    (, ,)
                    (NP (NNP WI) (, ,) (NNP USA))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Real-time) (NNP PCR))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN with)
          (NP
            (NP
              (NP (DT the) (NNP LightCycler) (NNP Instrument))
              (PRN (-LRB- -LRB-)
                (NP (NNP Roche) (NNPS Diagnostics))
                (, ,)
                (NP (NNP Penzberg))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-)))
            (PP (IN in)
              (NP (NN glass) (NNS capillaries)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN reaction) (NN mix))
      (VP (VBG containing)
        (NP
          (NP (NNP Taq) (NNP DNA) (NN polymerase)
            (CC and)
            (NNP DNA) (JJ double-strand-specific) (NN SYBR) (NNP Green) (NNP I) (NNP dye))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Lightcycler) (NNP FastStart) (NNP DNA) (NNP Master) (NNP SYBR) (NNP Green) (NNP I))
              (: ;)
              (NP (NNP Roche) (NNPS Diagnostics)))
            (-RRB- -RRB-))
          (CC and)
          (NP (JJ specific) (NNS primers)))))
    (VP (VBD were)
      (VP (VBN added)
        (PP (TO to)
          (NP (NN cDNA) (NNS dilutions)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN cDNA) (NNS samples))
    (VP
      (VP (VBD were)
        (VP (VBN denatured)
          (PP (IN at)
            (NP
              (NP (CD 95) (NNP °) (NNP C))
              (PP (IN for)
                (NP (CD 10) (NN min)))))))
      (, ,)
      (CC and)
      (VP (VBD were) (RB then)
        (VP (VBN amplified)
          (PP (IN for)
            (NP
              (NP
                (NP
                  (NP
                    (NP (CD 40))
                    (: --)
                    (NP (CD 50) (NNS cycles)))
                  (: :)
                  (NP
                    (ADVP (IN at)
                      (NP (CD 95)))
                    (NP (NNP °) (NNP C))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (QP (CD 10) (CD s)))
                      (-RRB- -RRB-))
                    (, ,)
                    (PP (IN at)
                      (NP
                        (NP (CD 65) (NNP °) (NNP C))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (QP (CD 15) (CD s)))
                          (-RRB- -RRB-)))))
                  (, ,)
                  (CC and)
                  (NP
                    (NP
                      (NP (CD 72) (NNP °) (NNP C))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (QP (CD 22) (CD s)))
                        (-RRB- -RRB-)))
                    (PP (IN for)
                      (NP (NN β-actin))))
                  (: ;)
                  (NP
                    (ADVP (IN at)
                      (NP (CD 95)))
                    (NP (NNP °) (NNP C))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (QP (CD 10) (CD s)))
                      (-RRB- -RRB-))
                    (, ,)
                    (PP (IN at)
                      (NP
                        (NP (CD 62) (NNP °) (NNP C))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (QP (CD 15) (CD s)))
                          (-RRB- -RRB-)))))
                  (, ,)
                  (CC and)
                  (PRN
                    (PP (IN at)
                      (NP (CD 72))))
                  (NP
                    (NP
                      (NP (NNP °) (NNP C))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (QP (CD 10) (CD s)))
                        (-RRB- -RRB-)))
                    (PP (IN for)
                      (NP (NNP SOCS1))))
                  (, ;)
                  (CC and)
                  (PRN
                    (PP (IN at)
                      (NP (CD 96))))
                  (NP
                    (NP (NNP °) (NNP C))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (QP (CD 10) (CD s)))
                      (-RRB- -RRB-)))
                  (, ,))
                (PP (IN at)
                  (NP
                    (NP (CD 68) (NNP °) (NNP C))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (QP (CD 15) (CD s)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (ADVP (IN at)
                (NP (CD 72)))
              (NP
                (NP
                  (NP (NNP °) (NNP C))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 15) (CD s)))
                    (-RRB- -RRB-)))
                (PP (IN for)
                  (NP (NNP SOCS3)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NN Amplification) (NNS curves))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ fluorescence) (NNS values))
            (PP (IN versus)
              (NP (NN cycle) (NN number))))))
      (VP (VBD were)
        (VP (VBN obtained))))
    (, ,)
    (CC and)
    (S
      (NP (DT a) (JJ melting) (NN curve) (NN analysis))
      (VP (VBD was)
        (VP
          (ADVP (RB then))
          (VBN performed))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNS levels))
      (PP (IN of)
        (NP (NN SOCS1)
          (CC and)
          (NN SOCS3) (NN expression))))
    (VP (VBD were)
      (VP (VBN determined)
        (PP (IN by)
          (S
            (VP (VBG normalizing)
              (ADVP (JJ relative))
              (PP (TO to)
                (NP (JJ β-actin) (NN expression))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ forward)
      (CC and)
      (JJ reverse) (NNS primers))
    (VP (VBD were)
      (PP (IN as)
        (NP
          (NP (NNP follows))
          (: :)
          (PP
            (PP (IN for)
              (NP
                (NP (NN β-actin))
                (, ,)
                (NP
                  (NP (CD 5) (POS '))
                  (PRN (: -)
                    (NP
                      (NP
                        (NP
                          (NP (NNP GTGGGGCGCCCCAGGCACCA-3) (POS '))
                          (CC and)
                          (NP (CD 5) (POS ')))
                        (PRN (: -)
                          (NP (NNP CTCCTTAATGTCACGCACGATTTC-3))
                          ('' ') (: ;)))
                      (PP (IN for)
                        (NP
                          (NP (NNP SOCS1))
                          (, ,)
                          (NP
                            (NP (CD 5) (POS '))
                            (JJ -) (NN AGACCCCTTCTCACCTCTTG-3))
                          ('' ')
                          (CC and)
                          (NP (CD 5) (POS ')))))
                    (: -))
                  (NN GCACAGCAGAAAAATAAAGC-3) ('' '))))
            (: ;)
            (CC and)
            (PP (IN for)
              (NP
                (NP (NNP SOCS3))
                (, ,)
                (NP
                  (NP (CD 5) (POS '))
                  (JJ -) (NN CCCGCCGGCACCTTTCTG-3))
                ('' ')
                (CC and)
                (NP (CD 5) (POS ')))))
          (: -)))
      (ADJP (JJ AGGGGCCGGCTCAACACC-3))
      ('' '))
    (. .)))

(ROOT
  (S
    (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP (VBD were)
      (VP (VBN stimulated)
        (PP (IN for)
          (NP (CD 20) (NN min)))
        (PP (IN by)
          (NP
            (NP (DT the) (JJ indicated) (NNS concentrations))
            (PP (IN of)
              (NP (NN IL-10)
                (CC and)
                (NN IL-6)))))
        (PP (IN at)
          (NP
            (NP (DT a) (NN density))
            (PP (IN of)
              (NP
                (NP (CD 5) (JJ ×) (CD 105) (NNS cells))
                (PP (IN in)
                  (NP
                    (NP (CD 0.5) (NN ml) (NN culture) (NN medium))
                    (PP (IN with)
                      (NP
                        (ADJP (CD 10) (NN %))
                        (NNP FCS)))))))))))
    (. .)))

(ROOT
  (FRAG
    (S
      (S
        (VP (TO To)
          (VP (VB examine)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NN serum) (NN IL-6))))
            (PP (IN on)
              (NP (JJ STAT) (NN phosphorylation))))))
      (, ,)
      (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells))
      (VP (VBD were)
        (VP (VBN stimulated)
          (PP (IN for)
            (NP
              (NP (CD 20) (NN min))
              (PP (IN with)
                (NP
                  (ADJP (CD 30) (NN %))
                  (JJ active) (NNP RA) (NN serum)))))
          (PP (IN in)
            (NP (NN culture) (NN medium)))
          (PP (IN with)
            (NP (CD 40) (NN μg))))))
    (: /)
    (FRAG
      (NP (NN ml))
      (S
        (VP (VBG neutralizing)
          (NP
            (NP
              (NP (JJ goat) (JJ anti-IL-6) (JJ polyclonal) (NN antibody))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP IgG))
                  (: ;)
                  (NP (NNP Techne) (, ,) (NNP Princeton) (, ,) (NNP NJ) (, ,) (NNP USA)))
                (-RRB- -RRB-)))
            (CC or)
            (NP
              (NP (NN control) (NN goat) (NN IgG))
              (PRN (-LRB- -LRB-)
                (NP (NNP Techne))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Whole) (NN cell) (NNS lysates))
    (VP (VBD were)
      (VP (VBN prepared)
        (PP (IN by)
          (S
            (VP (VBG placing)
              (NP (NNS cells))
              (PP (IN in)
                (NP
                  (NP (CD 100) (NNP μl) (NNP SDS) (NN lysing) (NN buffer))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 62.5) (NNP mM) (NNS Tris))
                    (: --)
                    (NP
                      (NP
                        (NP (NNP HCl) (NNP -LSB-) (NNP pH))
                        (NP
                          (QP (CD 6.8) (CD -RSB-))))
                      (, ,)
                      (NP
                        (NP
                          (ADJP (CD 2) (NN %))
                          (NNP SDS))
                        (, ,)
                        (NP
                          (ADJP (CD 10) (NN %))
                          (NN glycerol))
                        (, ,)
                        (ADJP
                          (NP (CD 50) (NNS mM))
                          (JJ dithiothreitol)))
                      (, ,)
                      (NP
                        (NP (CD 0.1) (NN %))
                        (ADJP (JJ bromphenol) (JJ blue))))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (ADVP (RB Then))
      (NP (CD 20) (NN μl) (NN protein) (NNS samples))
      (VP
        (VP (VBD were)
          (VP (VBN fractionated)
            (PP (IN on)
              (NP
                (ADJP (CD 10) (NN %))
                (JJ SDS-polyacrylamide) (NNS gels)))))
        (CC and)
        (VP (VBD were)
          (VP (VBN transferred)
            (PP (TO to)
              (NP
                (NP (JJ nitrocellulose) (NNS membranes))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Amersham))
                  (, ,)
                  (NP (NNP Buckinghamshire))
                  (, ,)
                  (NP (NNP UK))
                  (-RRB- -RRB-))))))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (NN membrane))
      (VP (VBD was)
        (VP (VBN blocked)
          (PP (IN with)
            (NP
              (NP
                (ADJP (CD 5) (NN %))
                (NN skim) (NN milk))
              (PP (IN in)
                (NP (JJ Tris-buffered) (NN saline)))))
          (PP (IN with)
            (NP (CD 0.1) (NN %)))
          (NP (NNP Tween) (CD 20)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Tyrosine) (NN phosphorylation))
      (PP (IN of)
        (NP (NNP STAT1)
          (CC and)
          (NNP STAT3))))
    (VP (VBD was)
      (VP (VBN detected)
        (S
          (VP (VBG using)
            (NP
              (NP
                (ADJP (JJ commercial) (JJ available))
                (NNS kits))
              (PRN (-LRB- -LRB-)
                (NP (NNP Cell) (NNP Signaling) (NNP Technology))
                (, ,)
                (NP (NNP Beverly))
                (, ,)
                (NP (NNP MA) (, ,) (NNP USA))
                (-RRB- -RRB-)))
            (PP (VBG according)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN manufacturer) (POS 's))
                  (NNS instructions))))))))
    (. .)))

(ROOT
  (SINV
    (S
      (ADVP (RB Briefly))
      (, ,)
      (NP (DT the) (NN membrane))
      (VP (VBD was)
        (VP (VBN incubated)
          (PP (IN with)
            (NP
              (NP
                (NP (DT the) (NNS antibodies))
                (PRN (-LRB- -LRB-)
                  (NP (NNP rabbit) (NNP IgG))
                  (-RRB- -RRB-))
                (NP (JJ anti-STAT1) (NN antibody)))
              (, ,)
              (NP
                (NP (JJ anti-phosphorylated) (NN tyrosine) (NNS 701))
                (PP (IN of)
                  (NP
                    (NP (JJ STAT1) (NN antibody))
                    (, ,)
                    (NP (JJ anti-STAT3) (NN antibody))
                    (, ,))))
              (CC and)
              (NP
                (NP (JJ anti-phosphorylated) (NN tyrosine) (NNS 705))
                (PP (IN of)
                  (NP (JJ STAT3) (NN antibody)))))))))
    (, ,)
    (VP (VBD diluted)
      (SBAR (IN as)
        (S
          (VP (VBD recommended)
            (PP (IN at)
              (NP (CD 1/2000)))
            (PP (IN with)
              (NP
                (NP (JJ Tris-buffered) (NN saline))
                (PP (IN with)
                  (NP (CD 0.1) (NN %)))))))))
    (NP
      (NP (NNP Tween) (CD 20))
      (PP (IN with)
        (NP
          (ADJP (CD 5) (NN %))
          (NNP BSA))))
    (. .)))

(ROOT
  (S
    (NP (NNP Antibody) (NNP binding))
    (VP
      (VP (VBD was)
        (VP (VBN detected)
          (PP (IN by)
            (NP
              (NP (NN horseradish) (JJ peroxidase-conjugated) (JJ anti-rabbit) (NN IgG) (NN antibody))
              (VP (VBN diluted)
                (PP (IN at)
                  (NP (CD 1/4000)))
                (PP (IN with)
                  (NP (JJ Tris-buffered) (NN saline)))
                (PP (IN with)
                  (NP
                    (NP (CD 0.1) (NN %))
                    (PP
                      (NP (NNP Tween) (CD 20))
                      (IN with)
                      (NP
                        (ADJP (CD 5) (NN %))
                        (NNP BSA))))))))))
      (, ,)
      (CC and)
      (VP (VBD was)
        (VP (VBN revealed)
          (S
            (VP (VBG using)
              (NP (DT the) (JJ chemiluminescence) (NN system)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NN Protein) (NNS bands))
      (VP (VBD were)
        (VP (VBN quantified)
          (PP (IN by)
            (S
              (ADVP (RB densitometry))
              (VP (VBG using)
                (NP (JJ NIH-Image) (NN analysis))))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP STAT) (NNP phosphorylation))
      (VP (VBD was)
        (VP (VBN compared)
          (PP (IN with)
            (NP
              (NP (DT the) (JJ total) (NN amount))
              (PP (IN of)
                (NP (JJ STAT) (NN protein))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ IFN-γ-stimulated) (NNP Hela) (NNS cells))
    (VP (VBD were)
      (VP (VBN used)
        (PP (IN as)
          (NP
            (NP (DT a) (JJ positive) (NN control))
            (PP (IN for)
              (NP (JJ STAT1) (NN phosophorylation)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Data))
    (VP (VBP are)
      (VP (VBN expressed)
        (PP (IN as)
          (NP
            (NP (DT the) (JJ mean) (NN value))
            (VP (VBG ±)
              (NP
                (NP (JJ standard) (NN error))
                (PP (IN of)
                  (NP (DT the) (NN mean)
                    (CC or)
                    (NN box) (NNS plots)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (JJ statistical) (NN significance))
        (PP (IN of)
          (NP
            (NP (NNS differences))
            (PP (IN between)
              (NP (CD two) (NNS groups))))))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (IN by)
            (NP (DT the) (NNP Mann))))))
    (: --)
    (S
      (NP
        (NP (NNP Whitney) (NNP U) (NN test))
        (CC or)
        (NP (DT the) (NNP Wilcoxon)))
      (VP (VBD signed)
        (NP (JJ rank) (NN test))))
    (. .)))

(ROOT
  (S
    (NP (NNP P) (NNP <) (CD 0.05))
    (VP (VBD was)
      (VP (VBN considered)
        (S
          (ADJP (JJ significant)))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NNS Results))
        (NP (DT The) (JJ CD28) (NN costimulatory) (NN pathway)))
      (VP (VBZ is)
        (ADJP (JJ crucial)
          (PP (IN for)
            (NP
              (ADJP (JJ effective) (JJ antigen-specific))
              (JJ T-cell) (NN cytokine) (NN production))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP IL-10))
      (VP (MD can)
        (ADVP (RB directly))
        (VP (VB suppress)
          (NP (DT this) (NN response))
          (PP (IN by)
            (S
              (VP (VBG inhibiting)
                (NP
                  (NP (JJ CD28) (NN tyrosine))
                  (ADJP (JJ phosphorylation)
                    (CC and)
                    (JJ binding))
                  (PP (IN of)
                    (NP
                      (ADJP (JJ phosphatidylinositol))
                      (JJ 3-kinase) (JJ -LSB-) (CD 24) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NNS responsiveness))
              (PP (IN of)
                (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))))
            (PP
              (PP (TO to)
                (NP
                  (NP (NN IL-10) (, ,) (NNP purified) (NNP PB) (NNP CD4) (NNP +) (NNP T) (NNS cells))
                  (PP (IN from)
                    (NP
                      (NP (CD three) (NNS patients))
                      (PP (IN with)
                        (NP (JJ active) (NNP RA)))))))
              (CC and)
              (PP (IN from)
                (NP (CD three) (JJ healthy) (NNS controls)))))))
      (VP (VBD were)
        (VP (VBN stimulated)
          (PP (IN by)
            (NP
              (NP (JJ immobilized) (JJ anti-CD3) (NN antibody))
              (CC and)
              (NP (JJ anti-CD28) (NN antibody))))
          (PP (IN with)
            (CC or)
            (IN without)
            (NP
              (NP (JJ diluted) (NNS concentrations))
              (PP (IN of)
                (NP
                  (NP (NN IL-10))
                  (PP (IN for)
                    (NP (CD 36) (NNS hours))))))))))
    (, ,)
    (CC and)
    (S
      (NP (JJ IFN-γ) (NN production))
      (VP (VBD was)
        (VP (VBN measured)
          (PP (IN by)
            (NP (NNP ELISA))))))
    (. .)))

(ROOT
  (SINV
    (S
      (SBAR (IN As)
        (S
          (VP (VBN shown)
            (PP (IN in)
              (NP (NNP Fig.) (CD 1) (, ,) (CD IFN-γ)))
            (NP
              (NP (NN production))
              (PP (IN by)
                (NP (VBN activated) (JJ normal) (NN CD4) (NNP +) (NNP T)))))))
      (NP (NNS cells))
      (VP (VBD was)
        (ADVP (RB mostly))))
    (VP (VBD inhibited)
      (PP (IN at)
        (NP (NNS concentrations))))
    (NP
      (QP (RB as) (JJ low) (IN as) (CD 1))
      (JJ ng/ml) (NN IL-10))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (S
      (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))
      (VP (VBD were)
        (ADJP (JJ able)
          (S
            (VP (TO to)
              (VP (VB produce)
                (NP
                  (NP (JJ significant) (NNS amounts))
                  (PP (IN of)
                    (NP (NNP IFN-γ))))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN presence))
                    (PP (IN of)
                      (NP (CD 1) (JJ ng/ml) (NN IL-10)))))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the)
          (ADJP (JJ maximal)
            (CONJP (CC but)
              (RB not))
            (JJ complete))
          (NN inhibition))
        (PP (IN by)
          (NP (NN IL-10))))
      (VP (VBD was)
        (VP (VBN obtained)
          (PP (IN at)
            (NP
              (NP (CD 10))
              (: --)
              (NP (CD 100) (NN ng/ml)))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB thus))
    (VP (VBD compared)
      (NP
        (NP (DT the) (NNS levels))
        (PP (IN of)
          (NP (JJ IFN-γ) (NN production))))
      (PP
        (PP (IN by)
          (NP
            (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
            (PP
              (PP (IN after)
                (NP (NNP CD3)))
              (CC and)
              (PP
                (NP
                  (NP (JJ CD28) (NN costimulation))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN presence))
                      (PP (IN of)
                        (NP
                          (NP (CD 1) (JJ ng/ml) (NN IL-10))
                          (PP (IN in)
                            (NP (NNP RA) (NNS patients))))))))
                (IN with)
                (NP
                  (NP (JJ active) (NN disease))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (JJ multiple) (JJ inflammatory) (NNS joints))
                      (, ,)
                      (NP (NNP CRP) (NN level) (NNP ≥) (CD 10) (NNP mg/l)))
                    (-RRB- -RRB-))
                  (CC and)
                  (NP (JJ inactive) (NN disease))
                  (PRN (-LRB- -LRB-)
                    (PP (IN in)
                      (NP
                        (NP (NN remission))
                        (, ,)
                        (NP
                          (NP (NNP CRP) (NN level) (NNP <))
                          (ADJP (CD 10) (JJ mg/l)))))
                    (-RRB- -RRB-))))
              (NP
                (QP (CD -LSB-) (CD 26))
                (NNS -RSB-)))))
        (CC and)
        (PP (IN in)
          (NP (JJ healthy) (NNS controls)))))
    (. .)))

(ROOT
  (S
    (S
      (NP (EX There))
      (VP (VBD were)
        (NP
          (NP (DT no)
            (ADJP (RB statistically) (JJ significant))
            (NNS differences))
          (PP (IN in)
            (NP (JJ IFN-γ) (NN production))))
        (PP (IN without)
          (NP
            (NP (NN IL-10))
            (PP (IN among)
              (NP
                (NP (DT these) (CD three) (NNS groups))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 2a))
                  (-RRB- -RRB-))))))))
    (, ,)
    (CC but)
    (S
      (NP
        (NP (DT the) (JJ inhibitory) (NN effect))
        (PP (IN of)
          (NP
            (NP (NN IL-10))
            (PP (IN on)
              (NP (JJ IFN-γ) (NN production))))))
      (VP (VBD was)
        (ADJP (RB significantly) (JJ limited)
          (PP (IN in)
            (NP
              (NP (DT the) (JJ active) (NNP RA) (NN group))
              (IN as))))
        (PP (VBN compared)
          (PP (IN with)
            (NP
              (NP
                (NP
                  (NP (DT the) (JJ inactive) (NNP RA) (NN group))
                  (CC and)
                  (NP (JJ healthy) (NNS controls)))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NN percentage) (NN decrease))
                    (: :)
                    (NP
                      (NP (JJ active) (NNS RA))
                      (, ,)
                      (NP
                        (NP
                          (NP (CD 2.9))
                          (NP
                            (QP (CD ±) (CD 14.4))
                            (NN %)))
                        (: ;)
                        (NP
                          (NP (NNP inactive) (CD RA) (, ,) (CD 45.6))
                          (NP
                            (QP (CD ±) (CD 14.4))
                            (NN %)))
                        (: ;)
                        (NP
                          (NP (NNS controls))
                          (, ,)
                          (NP
                            (NP (CD 65.8) (NNS ±))
                            (ADJP (CD 7.9) (NN %)))))))
                  (-RRB- -RRB-)))
              (PRN (-LRB- -LRB-)
                (NP (NNP Fig.) (CD 2b))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN As)
      (NP (DT a) (NN consequence)))
    (, ,)
    (NP
      (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
      (PP (IN from)
        (NP (JJ active) (NNP RA) (NNS patients))))
    (VP (VBD produced)
      (NP
        (NP (JJR higher) (NNS levels))
        (PP (IN of)
          (NP (NNP IFN-γ))))
      (PP (IN in)
        (NP
          (NP (DT the) (NN presence))
          (PP (IN of)
            (NP
              (NP (CD 1) (JJ ng/ml) (NN IL-10))
              (SBAR (IN than)
                (SINV (VBD did)
                  (NP
                    (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Fig.) (CD 2a))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP we))
    (VP (VBD compared)
      (NP (NN IL-2) (NN production))
      (PP (IN by)
        (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))
      (PP
        (PP (IN after)
          (NP
            (NP (NN CD3)
              (CC and)
              (NN CD28) (NN costimulation))
            (PP (IN in)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP
                    (NP (NN IL-10))
                    (PP (IN in)
                      (NP (JJ active) (NNP RA) (NNS patients)))))))))
        (CC and)
        (PP (IN in)
          (NP (JJ healthy) (NNS controls)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Similarly))
    (, ,)
    (NP (NN IL-2) (NN production))
    (VP (VBD was) (RB not)
      (VP (VBN affected)
        (PP (IN by)
          (NP
            (NP (CD 1) (JJ ng/ml) (NN IL-10))
            (PP (IN in)
              (NP (NNP RA) (NNS patients)))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN percentage) (NN decrease))
                (, ,)
                (NP
                  (NP (CD -2.1))
                  (VP (VBG ±)
                    (NP (CD 13.8) (NN %)))))
              (-RRB- -RRB-))))
        (, ,)
        (SBAR (IN while)
          (S
            (NP (PRP it))
            (VP (VBD was)
              (ADVP (RB significantly))
              (VP (VBN reduced)
                (PP (IN in)
                  (NP
                    (NP (JJ healthy) (NNS controls))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 61.1) (NNS ±))
                      (NP
                        (NP (CD 13.7) (NN %))
                        (: ;)
                        (NP (NNP P) (NNP <) (NNP 0.05)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBN Taken)
        (ADVP (RB together))))
    (, ,)
    (NP (DT these) (NNS results))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))
          (VP (VBP become)
            (ADJP (RBR less) (JJ susceptible)
              (PP (TO to)
                (NP
                  (NP (DT the) (JJ immunoregulatory) (NN effect))
                  (PP (IN of)
                    (NP (NN IL-10))))))
            (PP (IN during)
              (NP (DT the) (JJ active) (NN phase)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The)
        (ADJP (JJ functional))
        (NN receptor) (NN complex))
      (PP (IN of)
        (NP (NN IL-10))))
    (VP (VBZ consists)
      (PP (IN of)
        (NP
          (NP (CD two) (NNS subunits))
          (, ,)
          (NP (DT the) (JJ primary) (JJ ligand-binding) (NN component) (NN IL-10R1))
          (CC and)
          (NP
            (NP (DT the) (JJ accessory) (NN component) (NN type))
            (NP (CD 2) (NNP IL-10R) (NNP -LSB-) (CD 1) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP (NN IL-10R1) (NN expression))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ critical) (NN role))
        (PP (IN in)
          (NP (JJ cellular) (NNS responses))))
      (PP (TO to)
        (NP (NNP IL-10) (NNP -LSB-) (CD 29) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB examine)
          (SBAR (IN whether)
            (S
              (NP
                (NP (DT the) (NN resistance))
                (PP (TO to)
                  (NP
                    (NP (NN IL-10) (NN inhibition))
                    (PP (IN in)
                      (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))))))
              (VP (VBD was)
                (ADJP (JJ due)
                  (PP (TO to)
                    (NP (JJ limited) (NN receptor) (NN expression))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN cell) (NN surface) (NN expression))
      (PP (IN of)
        (NP
          (NP
            (ADJP (JJ IL-10R1)
              (PP (IN on)
                (NP (NNP PB) (NNP CD4) (NNP +) (NNP T))))
            (NNS cells))
          (PP
            (PP (IN from)
              (NP (JJ active) (NNP RA) (NNS patients)))
            (CC and)
            (PP (IN from)
              (NP (JJ healthy) (NNS controls)))))))
    (VP (VBD was)
      (VP (VBN determined)
        (PP (IN by)
          (NP (NN flow) (JJ cytometric) (NN analysis)))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (VP (VBN shown)
          (PP (IN in)
            (S
              (VP (VBG Fig.)
                (NP (CD 3a) (CD ,3))
                (X (SYM b))))))))
    (, ,)
    (NP
      (NP (DT the) (NN intensity))
      (PP (IN of)
        (NP
          (NP (NN IL-10R1) (NN expression))
          (PP (IN on)
            (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))))
    (VP (VBD was)
      (ADVP (RB significantly))
      (VP (VBN increased)
        (PP (IN in)
          (NP (NNP RA) (NNS patients)))
        (PP (VBN compared)
          (PP (IN with)
            (PP (IN in)
              (NP (JJ healthy) (NNS controls)))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN intracellular) (NN signal) (NN transduction) (NN pathway))
            (PP (IN of)
              (NP (NN IL-10))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN impaired)
                (PP (IN in)
                  (NP
                    (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
                    (PP (IN of)
                      (NP (JJ active) (NNP RA)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN interaction))
      (PP (IN of)
        (NP
          (NP (NN IL-10R))
          (PP (IN with)
            (NP (NN IL-10))))))
    (VP (VBZ induces)
      (NP
        (NP (JJ tyrosine) (NN phosphorylation)
          (CC and)
          (NN activation))
        (PP (IN of)
          (NP (DT the)
            (ADJP (JJ latent)
              (NP (CD transcription) (NNS factors)))
            (NN STAT1)
            (CC and)
            (NNP STAT3) (NNP -LSB-) (CD 3) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP (NNP Macrophage-specific) (NN STAT3-deficient) (NNS mice))
    (VP (VBD demonstrated)
      (SBAR (IN that)
        (S
          (NP (NNP STAT3))
          (VP (VBZ plays)
            (NP
              (NP (DT a) (JJ dominant) (NN role))
              (PP (IN in)
                (NP (JJ IL-10-mediated) (JJ anti-inflammatory) (NNS responses))))
            (NP
              (NP
                (QP (CD -LSB-) (CD 5))
                (NNS -RSB-))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBZ has)
                    (ADVP (RB recently))
                    (VP (VBN been)
                      (VP (VBN confirmed)
                        (PP (IN in)
                          (NP (JJ human) (NNS macrophages)))
                        (PP (IN by)
                          (NP
                            (NP (NNS studies))
                            (PP (IN of)
                              (NP (JJ dominant-negative) (NNP STAT3) (NN overexpression) (NN -LSB-)
                                (NP (CD 30) (NNS -RSB-))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN induction))
      (PP (IN of)
        (NP (NNP STAT1)
          (CC and)
          (NNP STAT3)))
      (VP (VBN phosphorylation)
        (PP (IN by)
          (NP
            (ADJP (JJ IL-10)
              (PP (IN in)
                (NP (NNP PB) (NNP CD4) (NNP +) (NNP T))))
            (NNS cells)))
        (PP
          (PP (IN from)
            (NP (JJ active) (NNP RA) (NNS patients)))
          (CC and)
          (PP (IN from)
            (NP (JJ healthy) (NNS controls))))))
    (VP (VBD was)
      (VP (VBN examined)
        (S
          (VP (VBG using)
            (NP (JJ western) (VBG blotting))))))
    (. .)))

(ROOT
  (S
    (NP (NNP STAT3) (NNP phosphorylation))
    (VP (VBD was)
      (ADVP (RB dose-dependently))
      (VP (VBN induced)
        (PP (IN after)
          (NP
            (NP (NN IL-10) (NN activation))
            (PP (IN for)
              (NP
                (NP (CD 20) (NN min))
                (PP (IN in)
                  (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
                (PRN (-LRB- -LRB-)
                  (S
                    (VP (VBG Fig.)
                      (NP (CD 4a) (CD ,4))
                      (X (SYM b))))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (S
      (NP (NNP STAT3))
      (VP (VBD was)
        (VP (VBN phosphorylated)
          (PP (IN in)
            (NP (RB freshly) (VBN isolated) (NNP PB) (NNP CD4) (VBG +) (NNS cells)))
          (PP (IN from)
            (NP (NNP RA) (NNS patients))))))
    (CC and)
    (S
      (NP (DT this) (NNP STAT3) (NN phosphorylation))
      (VP (VBD was)
        (ADJP (JJ detectable)
          (PP (IN for)
            (NP
              (QP (IN up) (TO to) (CD 6))
              (NNS hours))))))
    (. .)))

(ROOT
  (S
    (NP (NNP STAT3) (NNP phosphorylation))
    (VP (VBD was)
      (VP (VBN augmented)
        (SBAR (RB only)
          (WHADVP (WRB when))
          (S
            (VP (VBN activated)
              (PP (IN by)
                (NP
                  (QP (RB as) (JJ much) (IN as) (CD 10))
                  (NN ng/ml) (NN IL-10))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT Both) (JJ sustained) (NN STAT3) (NN phosphorylation))
      (CC and)
      (NP (JJ defective) (NN IL-10-induced) (NN STAT3) (NN phosphorylation)))
    (VP (VBD were)
      (VP (VBN found)
        (PP (IN in)
          (NP
            (NP (NNP RA) (NNP ST) (NNP CD4) (NNP +) (NNP T) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 4c))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (JJ other) (NN hand)))
    (, ,)
    (NP (NN IL-10-induced) (NN STAT1) (NN phosphorylation))
    (VP (VBD was) (RB not)
      (VP (VBN detected)
        (PP (IN in)
          (NP
            (NP (DT either) (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))
            (CC or)
            (NP
              (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NNP Fig.) (CD 4a))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT These) (NNS results))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (NP (NNP STAT3))
            (VP (VBZ is)
              (NP
                (NP (DT the) (JJ major) (NN IL-10-activated) (NN STAT))
                (PP (IN in)
                  (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))))))))
    (, ,)
    (CC and)
    (S
      (NP (NN IL-10-induced) (NN STAT3) (NN activation))
      (VP (MD may)
        (VP (VB be)
          (VP (VBN diminished)
            (PP (IN in)
              (NP (JJ active) (NNP RA)))
            (, ,)
            (PP (IN in)
              (NP
                (NP (NN association))
                (PP (IN with)
                  (NP (VBN sustained) (NNP STAT3) (NN phosphorylation)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP STAT3))
      (VP (VBZ is)
        (VP (VBN activated)
          (PP (IN by)
            (NP
              (NP (JJ many) (NNS cytokines)
                (CC and)
                (NN growth) (NNS factors))
              (PP (JJ such) (IN as)
                (NP
                  (NP
                    (NP (DT the) (NN IL-6) (NN family))
                    (PP (IN of)
                      (NP
                        (NP (NNS cytokines))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NN IL-6))
                            (, ,)
                            (NP (NN IL-11))
                            (, ,)
                            (NP (NN leukemia) (NN inhibitory) (NN factor))
                            (, ,)
                            (CC and)
                            (NP (NNP oncostatin) (NNP M)))
                          (-RRB- -RRB-))
                        (, ,)
                        (NP (JJ platelet-derived) (NN growth) (NN factor))
                        (, ,)
                        (CC and)
                        (NP (JJ epidermal) (NN growth) (NN factor)))))
                  (, ,)
                  (CONJP (IN in) (NN addition) (TO to))
                  (NP
                    (NP (NNP IL-10) (NNP -LSB-))
                    (NP (CD 4) (NNS -RSB-))))))))))
    (, ,)
    (CC but)
    (S
      (NP (JJ previous) (NNS studies))
      (VP (VBP have)
        (VP (VBN demonstrated)
          (SBAR (IN that)
            (S
              (NP (NNP IL-6))
              (VP (VBZ is)
                (NP
                  (NP (DT the) (JJ major) (NN factor))
                  (PP (IN in)
                    (NP (NNP RA) (JJ synovial) (NN fluid)))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBZ induces)
                        (NP
                          (NP (JJ constitutive) (NN activation))
                          (PP (IN of)
                            (NP (NNP STAT3))))
                        (PP (IN in)
                          (NP
                            (NP (NN mononuclear) (NNS cells))
                            (VP (VBG -LSB-)
                              (NP (CD 31) (NNS -RSB-)))))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Since)
      (S
        (NP (NNP IL-6))
        (VP (VBZ is)
          (ADVP (RB also))
          (ADJP (JJ abundant)
            (PP (IN in)
              (NP
                (NP (NN sera))
                (PP (IN of)
                  (NP (JJ active) (NNP RA) (NNS patients)))
                (, ,)
                (VP
                  (ADVP (RB frequently))
                  (VBN detected)
                  (PP (IN at)
                    (NP
                      (QP (CD >) (CD 1))
                      (JJ ng/ml) (JJ -LSB-) (CD 27) (NNS -RSB-))))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (SBAR (IN whether)
        (S
          (NP
            (NP (JJ persistent) (NN exposure))
            (PP (IN of)
              (NP
                (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
                (PP (TO to)
                  (NP
                    (NP (JJ high) (NNS concentrations))
                    (PP (IN of)
                      (NP
                        (NP (NN IL-6))
                        (PP (IN in)
                          (NP (DT the) (NN blood) (NN circulation))))))))))
          (VP (VBD was)
            (ADJP (JJ responsible)
              (PP (IN for)
                (NP
                  (NP (PRP$ their) (JJ sustained) (NN STAT3) (NN activation))
                  (CC and)
                  (NP (NN resistance)))))
            (PP (TO to)
              (NP
                (NP (NN IL-10) (NN inhibition))
                (PP (IN in)
                  (NP (JJ active) (NNP RA)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT Both) (NNP STAT1)
      (CC and)
      (NNP STAT3) (NN phosphorylation))
    (VP (VBD was)
      (VP (VBN activated)
        (PP (IN by)
          (NP
            (NP (NN IL-6))
            (PP (IN in)
              (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))
        (, ,)
        (PP (IN in)
          (S
            (NP
              (NP (NN agreement))
              (PP (IN with)
                (NP (JJ previous) (NNS observations))))
            (VP (VBG -LSB-)
              (NP (CD 4) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Normal) (NNP CD4) (NNP +) (NNP T) (NNS cells))
      (VP (VBD were)
        (VP
          (ADVP (RB thus))
          (VBN incubated)
          (PP (IN for)
            (NP
              (NP (CD 20) (NN min))
              (PP (IN with)
                (NP (NN culture) (NN medium)))))
          (S
            (VP
              (VP (VBG containing)
                (NP
                  (ADJP (CD 30) (NN %))
                  (NN serum))
                (PP (IN from)
                  (NP (JJ active) (NNP RA) (NNS patients))))
              (CC and)
              (VP (VBG neutralizing)
                (NP
                  (NP (JJ anti-IL-6) (NN antibody))
                  (CC or)
                  (NP (NN control) (NN antibody)))))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP STAT) (NNP phosphorylation))
      (VP (VBD was)
        (VP (VBN examined)
          (PP (IN by)
            (NP (JJ western) (NN blot) (NN analysis))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP RA) (NNP serum))
      (VP (VBD was)
        (ADJP (JJ able)
          (S
            (VP (TO to)
              (VP (VB induce)
                (NP
                  (NP (JJ tyrosine) (NN phosphorylation))
                  (PP (IN of)
                    (NP (NNP STAT3)
                      (CONJP (CC but)
                        (RB not))
                      (NNP STAT1))))))))))
    (, ,)
    (CC and)
    (S
      (NP (DT this) (NNP STAT3) (NN activation))
      (VP (VBD was)
        (ADVP (RB mostly))
        (VP (VBN abolished)
          (PP (IN by)
            (NP
              (NP (NN neutralization))
              (PP (IN of)
                (NP
                  (NP (NN IL-6) (NN activity))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Fig.) (CD 5a))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP (NNP IL-6))
          (VP (VBZ is)
            (NP
              (NP (DT the) (JJ dominant) (NN STAT3-activating) (NN factor))
              (VP (VBN contained)
                (PP (IN in)
                  (NP
                    (NP (NN sera))
                    (PP (IN of)
                      (NP (JJ active) (NNP RA) (NNS patients)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN lack))
      (PP (IN of)
        (NP
          (NP (JJ STAT1) (NN activation))
          (PP (IN by)
            (NP (NNP RA) (NNP serum))))))
    (VP (VBZ suggests)
      (SBAR
        (SBAR (IN that)
          (S
            (NP
              (NP
                (ADJP (RB much) (JJR higher))
                (NNS concentrations))
              (PP (IN of)
                (NP (NN IL-6))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN required)
                  (PP (IN for)
                    (ADVP
                      (NP (CD STAT1) (NNS activation))
                      (RB as)))
                  (PP (VBN compared)
                    (PP (IN with)
                      (NP (JJ STAT3) (NN activation)))))))))
        (, ,)
        (CC or)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS inhibitors))
              (PP (IN of)
                (NP (NNP STAT1) (NNP signaling))))
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ present)
                  (PP (IN in)
                    (NP (NNP RA) (NNP serum))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB next))
    (VP (VBD examined)
      (SBAR (IN whether)
        (S
          (NP (NNP IL-6))
          (VP (MD could)
            (VP (VB suppress)
              (NP
                (NP (DT the) (NN effect))
                (PP (IN of)
                  (NP
                    (ADJP (JJ IL-10)
                      (S
                        (VP (TO to)
                          (VP (VB inhibit)
                            (NP (JJ IFN-γ) (NN production))
                            (PP (IN by)
                              (NP (NNP CD4) (NNP +) (NNP T)))))))
                    (NNS cells)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN preincubation))
        (PP (IN with)
          (CC or)
          (IN without)
          (NP
            (NP (CD 10) (JJ ng/ml) (NN IL-6))
            (PP (IN for)
              (NP (CD 36) (NNS hours)))))))
    (, ,)
    (S
      (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells))
      (VP (VBD were)
        (VP (VBN stimulated)
          (PP (IN by)
            (NP (NN CD3)
              (CC and)
              (NN CD28) (NN costimulation)))
          (PP (IN in)
            (NP
              (NP (DT the) (NN presence)
                (CC or)
                (NN absence))
              (PP (IN of)
                (NP
                  (NP (CD 1) (JJ ng/ml) (NN IL-10))
                  (PP (IN for)
                    (NP (CD 36) (NNS hours))))))))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (JJ IFN-γ) (NN production))
      (VP (VBD was)
        (VP (VBN measured)
          (PP (IN by)
            (NP (NNP ELISA))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN IL-6) (NN pretreatment))
      (PP (IN of)
        (NP (JJ normal) (NNS cells))))
    (VP (VBD reduced)
      (NP
        (NP (NN IL-10-mediated) (NN inhibition))
        (PP (IN of)
          (NP
            (NP (JJ IFN-γ) (NN production))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 5b))
              (-RRB- -RRB-)))))
      (, ,)
      (S
        (VP (VBG indicating)
          (SBAR (IN that)
            (S
              (NP
                (NP (JJ high) (NNS concentrations))
                (PP (IN of)
                  (NP (NN IL-6))))
              (VP (MD could)
                (VP (VB modulate)
                  (NP (JJ T-cell) (NNS responsiveness))
                  (PP (TO to)
                    (NP (NN IL-10))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBN Taken)
        (ADVP (RB together))))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ persistent) (NN exposure))
            (PP (TO to)
              (NP (NN serum) (NN IL-6))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (PDT both) (DT the) (NN induction))
                    (PP (IN of)
                      (NP
                        (NP (JJ STAT3) (NN activation))
                        (CC and)
                        (NP (DT the) (NN resistance)))))))
              (PP (TO to)
                (NP
                  (NP (DT the) (JJ inhibitory) (NN effect))
                  (PP (IN of)
                    (NP
                      (ADJP (JJ IL-10)
                        (PP (IN in)
                          (NP (NNP RA) (NNP CD4) (NNP +) (NNP T))))
                      (NNS cells))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-6))
    (VP (VBZ induces)
      (NP
        (NP
          (NP (CD two) (JJ potent) (NNS inhibitors))
          (PP (IN of)
            (NP (NNP JAKs))))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NNP SOCS1))
            (CC and)
            (NP (CD SOCS3) (NNS proteins)))
          (-RRB- -RRB-))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP
              (CONJP (RB not) (JJ only))
              (VP (VBP act)
                (PP (IN as)
                  (NP
                    (NP (NNS mediators))
                    (PP (IN of)
                      (NP (JJ negative) (NN feedback) (NN inhibition))))))
              (, ,)
              (CC but)
              (VP
                (ADVP (RB also))
                (VBP play)
                (NP
                  (NP (DT a) (JJ major) (NN role))
                  (PP (IN in)
                    (NP (NN crosstalk) (NN inhibition)))))))))
      (PP (IN by)
        (S
          (VP (VBG opposing)
            (NP (JJ other) (JJ cytokine-signaling) (NNS pathways))
            (S
              (VP (VBG -LSB-)
                (NP (CD 7) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP SOCS3))
    (VP (VBZ has)
      (ADVP (RB recently))
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (ADVP (RB specifically))
                (VB inhibit)
                (NP
                  (NP (JJ STAT3) (NN activation))
                  (VP (VBN induced)
                    (PP
                      (PP (IN by)
                        (NP (NN IL-6)))
                      (CONJP (CC but)
                        (RB not))
                      (PP (IN by)
                        (NP (NN IL-10))))
                    (, ,)
                    (S
                      (ADVP (RB thereby))
                      (VP (VBG regulating)
                        (NP
                          (NP (DT the) (JJ divergent) (NN action))
                          (PP (IN of)
                            (NP
                              (ADJP (JJ IL-6)
                                (CC and)
                                (JJ IL-10))
                              (ADJP (JJ -LSB-)
                                (NP (CD 8,9)))
                              (NN -RSB-))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (NN contrary)))
    (, ,)
    (NP (NNP SOCS1))
    (VP (VBZ is)
      (ADJP (JJ able)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB partially))
              (VB inhibit)
              (NP
                (NP
                  (NP (NN IL-10-mediated) (NN STAT3) (NN activation))
                  (CC and)
                  (NP (JJ cellular) (NNS responses)))
                (, ,)
                (CONJP (RB as) (RB well) (IN as))
                (NP
                  (NP (JJ IFN-γ-mediated) (NNP STAT1) (NN activation) (NNS -LSB-))
                  (NP (CD 32) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB determine)
          (SBAR (IN whether)
            (S
              (NP (NNP SOCSs))
              (VP (VBD were)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (JJ defective) (NN IL-10-induced) (NN STAT3) (NN activation))
                      (PP (IN of)
                        (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))))))))))))
    (, ,)
    (NP
      (NP (DT the) (NNS levels))
      (PP (IN of)
        (NP
          (NP (NNP SOCS1)
            (CC and)
            (NNP SOCS3) (NNP mRNA) (NN expression))
          (PP (IN in)
            (NP
              (NP (NNP PB) (NNP CD4) (NNP +) (NNP T) (NNS cells))
              (PP
                (PP (IN from)
                  (NP (JJ active) (NNP RA) (NNS patients)))
                (CC and)
                (PP (IN from)
                  (NP (JJ healthy) (NNS controls)))))))))
    (VP (VBD were)
      (VP (VBN compared)
        (PP (IN by)
          (NP (JJ semiquantitative) (JJ real-time) (NN PCR)))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))
      (VP (VBD contained)
        (NP
          (NP (JJR higher) (NNS levels))
          (PP (IN of)
            (NP (NNP SOCS1))))))
    (CC but)
    (S
      (NP
        (NP (JJR lower) (NNS levels))
        (PP (IN of)
          (ADVP
            (NP (CD SOCS3) (NNS transcripts))
            (IN than))))
      (VP (VBD did)
        (VP (VB control)
          (NP
            (NP
              (QP (CD CD4) (CD +))
              (NNP T) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 6a))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Constitutive) (NN expression))
      (PP (IN of)
        (NP
          (NP (NNP SOCS1) (NNP mRNA))
          (PP (IN in)
            (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))))))
    (VP (VBD was)
      (ADJP (JJ comparable))
      (PP (IN with)
        (NP (DT the) (NN expression)))
      (PP (IN in)
        (NP
          (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells))
          (VP (VBN stimulated)
            (PP (IN by)
              (NP
                (NP (CD 10) (JJ ng/ml) (NN IL-6))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 6b))
                  (-RRB- -RRB-)))))))
      (, ,)
      (S
        (VP (VBG supporting)
          (NP (PRP$ its) (JJ functional) (NN significance)))))
    (. .)))

(ROOT
  (S
    (NP (NNP Defective) (NNP IL-10-induced) (NNP STAT3) (NNP activation))
    (ADVP (RB therefore))
    (VP (VBZ appears)
      (S
        (VP (TO to)
          (VP (VB be)
            (ADJP (JJ due)
              (PP
                (ADVP (IN at) (JJS least))
                (IN in)
                (NP (NN part))))
            (PP (TO to)
              (NP
                (NP (DT an) (NN abundance))
                (PP (IN of)
                  (NP (NNP SOCS1)))))
            (PP (IN in)
              (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Discussion) (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP (VBP orchestrate)
      (NP
        (NP (DT the)
          (ADJP (JJ Th1-type) (JJ cell-mediated))
          (JJ immune) (NN response))
        (PP (IN in)
          (NP (NNP RA) (NNP -LSB-) (CD 22) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP (NNP Activated) (NNP CD4))
    (VP (VBP +)
      (S
        (NP (NNP T) (NNS cells))
        (VP (VB stimulate)
          (NP
            (NP (NNS macrophages))
            (, ,)
            (NP (JJ synovial) (NNS fibroblasts))
            (, ,)
            (NP (NNP B) (NNS cells))
            (, ,)
            (CC and)
            (NP (NNS osteoclasts)))
          (PP (IN through)
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP
                  (NP (NN cell) (NN surface) (NNS molecules))
                  (CC and)
                  (NP (JJ Th1) (NNS cytokines))))))))
      (, ,)
      (S
        (ADVP (RB thereby))
        (VP (VBG contributing)
          (PP (TO to)
            (NP (PDT both)
              (NP (DT the) (JJ chronic) (NN inflammation))
              (CC and)
              (NP (DT the) (JJ joint) (NN destruction)))))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (NNP CD4) (NNP +) (NNP T))
      (SBAR
        (S
          (NP (NNS cells))
          (VP (VBP require)
            (NP (CD two) (NNS signals))
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN activated)))))))))
    (: ;)
    (NP
      (NP (NN antigen) (NN receptor) (NN occupancy))
      (CC and)
      (NP (NN CD28-mediated) (NN costimulation)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (NNP ST) (NN lesion)))
    (, ,)
    (NP
      (NP (DT the) (CD CD28) (NNS ligands))
      (, ,)
      (NP
        (NP (CC both)
          (CD CD80)
          (CC and)
          (CD CD86))
        (, ,)
        (ADVP (RB together)
          (PP (IN with)
            (NP (NNP MHC) (NN class) (NNP II) (NNP antigens)))))
      (, ,))
    (VP (VBP are)
      (ADVP (RB substantially))
      (VP (VBN expressed)
        (PP (IN by)
          (NP
            (NP (JJ antigen-presenting) (NNS cells))
            (PP (JJ such) (IN as)
              (NP
                (NP (NNS macrophages))
                (CC and)
                (NP (JJ dendritic) (NNS cells))))))
        (S
          (VP (VBG -LSB-)
            (NP (CD 18-20) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN significance))
        (PP (IN of)
          (NP
            (NP (JJ CD28) (NN engagement))
            (PP (IN in)
              (NP (DT the) (JJ T-cell-mediated) (NN disease) (NN process))))))
      (VP (VBZ has)
        (ADVP (RB recently))
        (VP (VBN been)
          (VP (VBN proven)
            (PP (IN by)
              (NP
                (NP (DT the) (JJ clinical) (NN efficacy))
                (PP (IN of)
                  (NP
                    (NP (PRP$ its) (NN blocker) (CD cytotoxic) (JJ T-cell-associated) (NN antigen) (CD 4))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CD152))
                      (-RRB- -RRB-))))))))))
    (: -)
    (S
      (NP
        (NP (NNP IgG))
        (PP (IN in)
          (NP (NNP RA) (NNS patients))))
      (VP (VBZ -LSB-)
        (NP (CD 23) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-10))
    (VP (VBZ plays)
      (NP (DT a) (JJ predominant) (NN role))
      (PP (IN in)
        (S
          (VP (VBG limiting)
            (NP
              (ADJP (JJ immune)
                (CC and)
                (JJ inflammatory))
              (NNS responses))
            (PP (IN by)
              (S
                (VP (VBG regulating)
                  (NP
                    (NP
                      (NP (DT the) (NN function))
                      (PP (IN of)
                        (NP (DT both) (NNS macrophages))))
                    (CC and)
                    (NP
                      (NP (JJ Th1) (NNS cells))
                      (NP
                        (QP (CD -LSB-) (CD 1))
                        (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-10))
    (VP
      (VP (VBZ inhibits)
        (NP
          (NP
            (NP (DT the) (JJ tyrosine) (NN phosphorylation))
            (PP (IN of)
              (NP (DT the) (NNP CD28) (NN molecule))))
          (CC and)
          (NP
            (NP (DT the) (JJ subsequent) (NN phosphatidylinositol))
            (ADJP (JJ 3-kinase) (JJ binding))))
        (PP (IN in)
          (NP (NNP T) (NNS cells))))
      (, ,)
      (CC and)
      (ADVP (RB thereby))
      (VP
        (ADVP (RB directly))
        (VBZ acts)
        (PP (IN on)
          (NP (NNP T) (NNS cells) (NNP -LSB-) (NNP 24) (NNP -RSB-)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNP PB) (NNP CD4) (NNP +) (NNP T) (NNS cells))
            (PP (IN from)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP (JJ active) (NNP RA))))))
          (, ,)
          (PP (IN in)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (NN IL-10)))))
          (, ,)
          (VP (VBP are)
            (ADJP (JJ able)
              (S
                (VP (TO to)
                  (VP (VB produce)
                    (NP
                      (NP (JJR higher) (NNS levels))
                      (PP (IN of)
                        (NP
                          (ADJP (JJ IFN-γ)
                            (PP (IN after)
                              (NP (NNP CD3)
                                (CC and)
                                (NNP CD28))))
                          (NN costimulation))))
                    (PP (IN than)
                      (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN Despite)
      (NP (JJ high-level) (NN IL-10R1) (NN expression)
        (CC and)
        (NN constitutive) (NN STAT3) (NN activation)))
    (, ,)
    (NP
      (NP (NN IL-10-induced) (NN tyrosine) (NN phosphorylation))
      (PP (IN of)
        (NP (NNP STAT3))))
    (VP (VBZ is)
      (VP (VBN suppressed)
        (PP (IN in)
          (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
        (, ,)
        (PP (IN in)
          (NP
            (NP (NN contrast))
            (PP (TO to)
              (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
            (, ,)
            (SBAR
              (WHADVP (WRB where))
              (S
                (NP (NNP STAT3) (NNP phosphorylation))
                (VP (VBZ is)
                  (NP
                    (NP (JJ dose-dependently) (NN inducible))
                    (PP (IN by)
                      (NP (NN IL-10)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NNP Serum) (NNP IL-6))
        (PP (IN from)
          (NP (NNP RA) (NNS patients))))
      (VP (VBZ induces)
        (NP
          (NP (NNP STAT3))
          (CONJP (CC but)
            (RB not))
          (NP (JJ STAT1) (NN phosphorylation)))
        (PP (IN in)
          (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells)))))
    (, ,)
    (CC and)
    (S
      (NP (JJ exogenous) (NN IL-6))
      (VP (VBZ induces)
        (NP (DT the) (NN resistance))
        (PP (TO to)
          (NP
            (NP (NN IL-10) (NN inhibition))
            (PP (IN of)
              (NP (JJ IFN-γ) (NN production)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP
      (VP (VBP contain)
        (NP
          (NP (JJR higher) (NNS levels))
          (PP (IN of)
            (NP (NNP SOCS1)))))
      (CC but)
      (VP (VBP contain)
        (NP
          (NP (JJR lower) (NNS levels))
          (PP (IN of)
            (NP
              (NP (CD SOCS3) (NNS transcripts))
              (PP (IN in)
                (NP
                  (NP (NN comparison))
                  (PP (IN with)
                    (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
            (VP (VBP become)
              (ADJP (JJ resistant)
                (PP (TO to)
                  (NP
                    (NP (DT the) (JJ inhibitory) (NN effect))
                    (PP (IN of)
                      (NP
                        (NP (NN IL-10))
                        (PP (IN before)
                          (NP (NN migration))))))))
              (PP (IN into)
                (NP (DT the) (JJ inflamed) (NN ST)))))))
      (, ,)
      (CC and)
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (DT this) (NN resistance))
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ attributable)
                  (PP (TO to)
                    (NP (VBN impaired) (NN IL-10-dependent) (NN STAT3) (NN activation)))))))))
      (, ,)
      (PP (IN in)
        (NP
          (NP (NN association))
          (PP (IN with)
            (NP (VBN sustained) (NNP STAT3) (NN phosphorylation)
              (CC and)
              (NN SOCS1) (NNS induction))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ IL-10-mediated) (NN inhibition))
      (PP (IN of)
        (NP (NNP CD4) (NNP +) (NNP T-cell) (JJ cytokine) (NN production))))
    (VP (VBZ is)
      (ADJP (RB principally) (JJ dependent)
        (PP (IN on)
          (NP
            (NP (PRP$ its) (NN inhibition))
            (PP (IN of)
              (NP (JJ macrophage) (JJ antigen-presenting) (NN cell) (NN function))))))
      (S
        (VP (VBG -LSB-)
          (NP (CD 1) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (S
      (NP (DT this) (JJ indirect) (NN inhibitory) (NN effect))
      (VP (VBZ is)
        (VP (VBN thought)
          (S
            (VP (TO to)
              (VP (VB be)
                (VP (VBN restricted)
                  (PP (IN at)
                    (NP
                      (NP (DT the) (NN site))
                      (PP (IN of)
                        (NP
                          (NP (JJ T-cell) (NN activation))
                          (PP (IN in)
                            (NP (NNP RA)))))))))))
          (, ,)
          (SBAR (IN because)
            (S
              (NP
                (NP (NNS macrophages))
                (PP (IN in)
                  (NP (DT the) (NNP ST))))
              (VP (VBP express)
                (NP
                  (NP (JJ high) (NNS levels))
                  (PP (IN of)
                    (NP (NNS cytokines) (, ,) (NN CD80)
                      (CC and)
                      (NN CD86) (NNS molecules))))))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP MHC) (NN class) (NNP II))
      (VP (VBZ antigens)
        (S
          (VP (VBG -LSB-)
            (NP (CD 10,18-20) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RBR More) (RB recently))
    (, ,)
    (NP (NNP IL-10))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB induce)
                (NP (DT the) (JJ antigen-specific) (JJ T-cell) (NNS unresponsiveness))
                (PP (IN by)
                  (S
                    (VP (VBG inhibiting)
                      (NP (NNP CD28) (NN tyrosine) (NN phosphorylation) (NNP -LSB-) (CD 33) (NNP -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (JJ direct) (NN effect))
    (ADVP (RB also))
    (VP (MD may)
      (VP (VB be)
        (VP (VBN limited)
          (PP (IN in)
            (NP (JJ active) (NNP RA) (NNS patients)))
          (, ,)
          (SBAR (IN because)
            (S
              (NP (PRP$ their) (NNP PB) (NNP CD4) (NNP +) (NNP T) (NNS cells))
              (VP (VBD showed)
                (NP
                  (NP (DT a) (JJ defective) (NN IL-10) (NN inhibition))
                  (PP (IN of)
                    (NP
                      (NP (NN CD28-costimulated) (NN production))
                      (PP (IN of)
                        (NP (DT both) (NNP IFN-γ)
                          (CC and)
                          (NNP IL-2))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (JJ Numerous) (NNS cytokines))
        (, ,)
        (ADJP (DT both) (JJ proinflammatory)
          (CC and)
          (JJ anti-inflammatory))
        (, ,))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN detected)
            (PP (IN in)
              (NP
                (NP (DT the) (NNP ST))
                (PP (IN of)
                  (NP (NNP RA)))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (NN balance))
        (PP (IN between)
          (NP (DT these) (JJ opposing) (JJ cytokine) (NNS activities))))
      (VP (VBZ regulates)
        (NP (NN disease) (NN severity) (NNP -LSB-) (CD 10) (NNP -RSB-))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Endogenous) (NNP IL-10))
      (, ,)
      (VP (VBN produced)
        (ADVP (RB mainly))
        (PP (IN by)
          (NP
            (NP (NNS macrophages))
            (CC and)
            (NP (NNP T) (NNS cells)))))
      (, ,))
    (VP (VBZ inhibits)
      (NP
        (ADJP (RB proinflammatory) (JJ cytokine))
        (NN production))
      (PP (IN by)
        (S
          (NP (NNP ST) (NNS cells))
          (VP (VBG -LSB-)
            (NP (CD 12) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (DT this) (JJ regulatory) (NN activity))
    (VP (VBZ seems)
      (S
        (VP (TO to)
          (VP (VB be)
            (VP (VBN restricted)
              (PP (IN during)
                (NP (JJ chronic) (NN inflammation))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN activation))
      (PP (IN of)
        (NP
          (NP (PDT both) (DT the) (NN extracellular) (JJ stimulus-regulated) (NN kinase)
            (CC and)
            (JJ p38) (NN kinase) (NNS pathways))
          (, ,)
          (VP (VBN induced)
            (PP (IN by)
              (NP (NNP TNF-α)
                (CC and)
                (NNP IL-1))))
          (, ,))))
    (VP (VBZ inhibits)
      (NP
        (NP (DT the) (NNS Jak1))
        (: --)
        (NP
          (NP (NNP STAT3) (NNP signaling))
          (VP
            (ADVP (RB pathway))
            (VBN shared)
            (PP (IN by)
              (NP (NN IL-10)
                (CC and)
                (NN IL-6)))
            (PP (IN in)
              (NP (JJ adhered) (NNS macrophages)))
            (S
              (VP (VBG -LSB-)
                (NP (CD 13) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RBR More) (RB importantly))
    (, ,)
    (NP (NN IL-10-mediated) (NN STAT3) (NN activation))
    (VP (VBZ is)
      (ADJP (RB mostly) (JJ undetectable)
        (PP (IN in)
          (NP (NNP RA) (NN synovial) (NNS macrophages)))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP
        (NP (DT This) (VBN impaired) (NN IL-10))
        (VP (VBG signaling)))
      (VP (VBZ is)
        (ADVP (RB probably))
        (VP (VBN induced)
          (PP (IN by)
            (NP (JJ chronic) (NN exposure)))
          (PP (TO to)
            (NP
              (NP (JJ immune) (NNS complexes))
              (PP (IN in)
                (NP (NN vivo)))))
          (, ,)
          (PP (IN because)
            (NP (DT both) (NN cell) (NN surface) (NN IL-10R1) (NN expression)
              (CC and)
              (NN IL-10-induced) (NNS Jak1) (NN activation))))))
    (VP (VBP are)
      (VP (VBN suppressed)
        (PP (IN in)
          (NP (JJ IFN-γ-primed) (NNS macrophages)))
        (PP (IN by)
          (NP (DT a) (NN protein) (NN kinase)))))
    (NP
      (NP (JJ C-dependent) (NN pathway) (VBG following) (NN ligation))
      (PP (IN of)
        (NP
          (NP (DT the) (NNP IgG) (NNP Fc) (NN gamma) (NN receptor))
          (VP (VBG -LSB-)
            (NP (CD 14) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (JJ dendritic) (NNS cells))
      (PP (IN from)
        (NP (NNP RA) (NN synovial) (NNS fluids))))
    (VP (VBP are)
      (ADJP (JJ resistant)
        (PP (TO to)
          (NP
            (NP (DT the) (JJ immunoregulatory) (NN effect))
            (PP (IN of)
              (NP
                (NP
                  (ADJP (JJ IL-10))
                  (ADJP (JJ due)
                    (PP (TO to)
                      (NP
                        (NP (VBN decreased) (NN transport))
                        (PP (IN of)
                          (NP
                            (NP (NN intracellular) (NN IL-10R1))
                            (PP (IN in)
                              (NP
                                (NP (DT the) (NN presence))
                                (PP (IN of)
                                  (NP
                                    (NP
                                      (ADJP (RB proinflammatory) (JJ cytokine))
                                      (NNS stimuli))
                                    (PP (JJ such) (IN as)
                                      (NP (NNP TNF-α)))))
                                (, ,)
                                (ADJP
                                  (ADJP (JJ IL-1))
                                  (, ,)
                                  (CC and)
                                  (ADJP (JJ granulocyte))
                                  (: --)))))))))
                  (JJ macrophage) (JJ colony-stimulating) (NN factor) (NNS -LSB-))
                (ADJP (CD 15) (JJ -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN resistance))
              (PP (IN of)
                (NP
                  (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))
                  (PP (TO to)
                    (NP (NN IL-10))))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP
                    (PP (IN with)
                      (NP (JJ defective) (NN IL-10-dependent) (NN STAT3) (NN activation)))
                    (, ,)
                    (CC but)
                    (RB not)
                    (PP (IN with)
                      (NP (NN IL-10R1) (NN expression)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Inhibitory) (NNS effects))
      (PP (IN of)
        (NP
          (ADJP (JJ IL-10)
            (PP (IN on)
              (NP (DT these) (JJ inflammatory) (NN cell))))
          (NNS types))))
    (VP (VBP are)
      (ADVP (RB therefore))
      (VP
        (ADVP (RB differentially))
        (VBN modulated)
        (PP (IN at)
          (NP (DT the) (NN signal) (NN transduction) (NN level)))
        (PP (IN under)
          (NP
            (NP (DT the) (JJ inflammatory) (NN environment))
            (PP (IN in)
              (NP (NNP RA)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN association))
        (PP (IN with)
          (NP (VBN impaired) (NN IL-10-mediated) (NN STAT3) (NN activation)))))
    (, ,)
    (NP (NNP STAT3))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP
                (ADVP (RB tyrosine))
                (VBN phosphorylated)
                (ADVP (RB persistently))
                (PP
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (IN up) (TO to) (CD 6))
                      (NNS hours))
                    (-RRB- -RRB-))
                  (IN in)
                  (NP (RB freshly) (VBN isolated) (NNP PB)
                    (CC and)
                    (NNP ST) (NNP CD4) (NNP +) (NNP T) (NNS cells)))))))
        (PP (IN from)
          (NP (NNP RA) (NNS patients)))))
    (. .)))

(ROOT
  (S
    (NP (NNP STAT3))
    (VP (VBZ is)
      (VP (VBN activated)
        (PP (IN by)
          (NP
            (NP
              (NP (DT a) (NN variety))
              (PP (IN of)
                (NP (NNS cytokines))))
            (, ,)
            (NP
              (NP (RB notably) (DT the) (NN IL-6) (NN family))
              (PP (IN of)
                (NP
                  (NP (NNS cytokines))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP e.g.) (NNP IL-6))
                      (, ,)
                      (NP (NN IL-11))
                      (, ,)
                      (NP (NN leukemia) (NN inhibitory) (NN factor))
                      (, ,)
                      (CC and)
                      (NP (NNP oncostatin) (NNP M)))
                    (-RRB- -RRB-)))))
            (CC and)
            (NP
              (NP (NN growth) (NNS factors))
              (, ,)
              (CONJP (IN in) (NN addition) (TO to))
              (NP (NNP IL-10) (NNP -LSB-) (CD 4) (NNP -RSB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN Of)
      (NP (DT these) (NNS cytokines)))
    (, ,)
    (NP (NNP IL-6))
    (VP (VBZ plays)
      (NP (DT a) (JJ predominant) (NN role))
      (PP (IN in)
        (S
          (VP (VBG eliciting)
            (NP
              (NP (DT a) (JJ systemic) (NN reaction))
              (PP (JJ such) (IN as)
                (NP
                  (NP (DT the) (JJ acute) (NN phase) (NN response))
                  (PP (IN in)
                    (NP
                      (ADJP (JJ active) (VBG RA))
                      (, ,)
                      (ADJP (JJ due)
                        (PP
                          (ADVP (RB mainly))
                          (TO to)
                          (NP
                            (NP (PRP$ its) (NN abundance))
                            (PP (IN in)
                              (NP (DT the) (NN blood) (NN circulation))))))
                      (ADJP (JJ -LSB-)
                        (NP (CD 27)))
                      (NNP -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NNP Consistent))
        (PP (IN with)
          (NP
            (NP (DT this) (NN notion))
            (, ,)
            (NP (NN IL-6)))))
      (VP (VBD was)
        (NP
          (NP (DT the) (JJ major) (NN STAT3-activating) (NN factor))
          (VP (VBN contained)
            (PP (IN in)
              (NP
                (NP (DT the) (NN serum))
                (PP (IN of)
                  (NP (JJ active) (NNP RA) (NNS patients)))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (NNS responsiveness))
        (PP (TO to)
          (NP (NN IL-10))))
      (VP (VBD was)
        (VP (VBN suppressed)
          (PP (IN in)
            (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
          (PP (IN after)
            (NP
              (NP (CD 36) (NNS hours))
              (PP (IN of)
                (NP (NN incubation)))))
          (PP (IN with)
            (NP (NN IL-6))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (PDT both) (DT the) (VBN sustained) (NN STAT3) (NNS activation))
            (CC and)
            (NP (DT the) (NN resistance))
            (PP (TO to)
              (NP
                (NP (NN IL-10) (NN inhibition))
                (VP (VBN found)
                  (PP (IN in)
                    (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells)))))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN induced)
                (PP (IN after)
                  (NP
                    (NP (JJ chronic) (NN exposure))
                    (PP (IN in)
                      (NP (NN vivo)))))
                (PP (TO to)
                  (NP
                    (NP (JJ high) (NNS concentrations))
                    (PP (IN of)
                      (NP (NN serum) (NN IL-6)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (ADVP (RB also))
      (ADJP (JJ possible))
      (SBAR (IN that)
        (S
          (NP (NNP STAT3) (NN activity))
          (VP (MD could)
            (VP (VB be)
              (VP
                (ADVP (RB constitutively))
                (VBN induced)
                (PP (IN in)
                  (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))
                (PP (IN by)
                  (NP
                    (NP (PRP$ their) (JJ own) (NN IL-10) (NN secretion))
                    (, ,)
                    (VP (VBG leading)
                      (PP (TO to)
                        (NP
                          (NP (DT the) (NN loss))
                          (PP (IN of)
                            (NP (NN sensitivity)))))
                      (PP (TO to)
                        (NP (JJ exogenous) (NN IL-10)))
                      (, ,)
                      (SBAR (IN because)
                        (S
                          (NP
                            (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))
                            (PP (IN in)
                              (NP (DT the) (NNP ST))))
                          (VP (VBP are)
                            (ADJP (JJ capable)
                              (PP (IN of)
                                (S
                                  (VP (VBG producing)
                                    (NP
                                      (NP (JJ significant) (NNS levels))
                                      (PP (IN of)
                                        (NP (NNP IL-10) (NNP -LSB-) (CD 34) (NNS -RSB-))))))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
      (VP (VBN isolated)
        (PP (IN from)
          (NP
            (NP (DT the) (NNP ST))
            (PP (IN of)
              (NP (NNP RA)))))))
    (ADVP (RB also))
    (VP (VBD showed)
      (NP
        (NP (DT a) (NN defect))
        (PP (IN in)
          (NP
            (NP (DT the) (NN IL-10-induced) (NN STAT3))
            (VP (VBG signaling)
              (ADVP (RB pathway)))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (ADJP
        (ADJP (RBS most) (JJ probable))
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN resistance))
              (PP (IN of)
                (NP
                  (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
                  (PP (TO to)
                    (NP (NN IL-10))))))
            (VP (MD can)
              (VP (VB be)
                (VP
                  (ADVP (RB even))
                  (VBN augmented)
                  (PP (IN after)
                    (NP (NN migration)))
                  (PP (IN into)
                    (NP (DT the) (JJ inflamed) (NN ST)))))))))
      (, ,)
      (SBAR (IN because)
        (S
          (NP (NNP IL-6))
          (VP (VBZ is)
            (ADJP (RB highly) (JJ concentrated))
            (PP (VBN compared)
              (PP (IN with)
                (NP
                  (NP (DT the) (NN blood) (NN level))
                  (VP (VBG -LSB-)
                    (NP (CD 27) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (DT the) (NN involvement))
      (PP (IN of)
        (NP
          (NP (JJ other) (JJ essential) (JJ proinflammatory) (NNS cytokines))
          (PP (IN in)
            (NP (DT this) (NN process))))))
    (VP (VBD was)
      (VP (VBN suggested)
        (PP (IN by)
          (NP
            (NP (PRP$ our) (JJ preliminary) (NNS experiments))
            (VP (VBG demonstrating)
              (SBAR (IN that)
                (S
                  (NP
                    (NP (NN IL-10-mediated) (NN IFN-γ) (NN inhibition))
                    (PP (IN in)
                      (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
                  (VP (VBD was)
                    (VP
                      (VP (VBN reduced)
                        (PP (IN by)
                          (NP (NN pretreatment)))
                        (PP (IN with)
                          (NP (NNS IL-1β))))
                      (CC and)
                      (VP
                        (ADJP
                          (ADJP (JJ TNF-α))
                          (, ,) (IN although)
                          (ADJP (JJR less)))
                        (PP
                          (ADVP (RB effectively))
                          (IN than) (IN by)
                          (NP (NN IL-6)))))))))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP IFN-γ)
      (CC and)
      (NNP IL-10))
    (VP (VBD produced)
      (PP (IN by)
        (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))
      (SBAR
        (S
          (NP (PRP themselves))
          (VP (MD could)
            (VP (VB be)
              (ADJP (JJ responsible)
                (PP (IN for)
                  (NP
                    (NP (VBN impaired) (NN IL-10))
                    (VP (VBG signaling)
                      (PP (IN in)
                        (NP (DT the) (NNP ST)))))))
              (, ,)
              (SBAR (IN because)
                (S
                  (NP (JJ T-cell) (NNS infiltrates))
                  (VP (VBP produce)
                    (SBAR
                      (S
                        (NP (DT both) (NNS cytokines))
                        (VP (VBZ -LSB-)
                          (NP (CD 34,35) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT an) (JJ autocrine) (NN fashion)))
    (, ,)
    (S
      (NP (NNP IL-10))
      (VP (MD may)
        (ADVP (RB persistently))
        (VP (VB stimulate)
          (NP (JJ STAT3) (NN activation)))))
    (CC and)
    (S
      (NP (NNP IFN-γ))
      (VP (MD can)
        (VP (VB induce)
          (NP (JJ SOCS1) (NN protein))
          (PP (IN as)
            (S
              (NP
                (NP (DT a) (NN crosstalk) (NN inhibitor))
                (PP (IN of)
                  (NP (NN IL-10))))
              (VP (VBG signaling)
                (NP
                  (QP (CD -LSB-) (CD 32))
                  (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ T-cell-inhibitory) (NN effect))
      (PP (IN of)
        (NP (NN IL-10))))
    (VP (MD may)
      (ADVP (RB therefore))
      (VP (VB be)
        (VP (VBN modulated)
          (ADVP (RB complicatedly))
          (PP (IN upon)
            (NP (NN exposure)))
          (PP (TO to)
            (NP
              (NP (DT an) (JJ inflammatory) (NN environment))
              (PP (IN in)
                (NP (NNP RA) (NNS joints)))))
          (, ,)
          (SBAR
            (WHADVP (WRB where))
            (S
              (NP (JJ many) (NNS cytokines))
              (VP (VBP are)
                (ADJP (JJ present) (RB substantially)
                  (S
                    (VP (VBG -LSB-)
                      (NP (CD 10) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP STAT3) (NNP activation))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN implicated)
          (PP (IN in)
            (NP
              (NP (DT the) (NNS pathogenesis))
              (PP (IN of)
                (NP (NNP RA))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Active) (NNP STAT3))
    (VP (VBZ is)
      (ADVP (RB constitutively))
      (VP (VBN expressed)
        (PP (IN in)
          (NP (JJ synovial) (JJ fluid) (NN mononuclear) (NNS cells)))
        (PP (IN from)
          (S
            (NP (NNP RA) (NNS patients))
            (VP (VBG -LSB-)
              (NP (CD 36) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-6))
    (VP (VBZ is)
      (NP
        (NP (DT the) (JJ major) (NN STAT3-activating) (NN factor) (NN present))
        (PP (IN in)
          (NP
            (NP (JJ synovial) (NN fluid))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBZ has)
                  (NP
                    (NP (DT a) (JJ crucial) (NN role))
                    (PP
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN activation))
                          (PP (IN of)
                            (NP
                              (NP (JJ monocyte) (NNS functions))
                              (PP (JJ such) (IN as)
                                (NP
                                  (NP (NN gene) (NN expression))
                                  (PP (IN of)
                                    (NP (DT the) (NNP Fc) (NN gamma) (NN receptor) (NN type) (NN I)
                                      (CC and)
                                      (NN type) (NN III)))))))))
                      (CC and)
                      (PP (IN of)
                        (NP (NNP HLA-DR) (NNP -LSB-)))
                      (NP (CD 31) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RBR More) (RB recently))
    (, ,)
    (S
      (NP
        (NP (JJ high) (NNS levels))
        (PP (IN of)
          (NP (VBN activated) (NN STAT3)))
        (, ,)
        (VP (VBN thought)
          (S
            (VP (TO to)
              (VP (VB be)
                (VP (VBN induced)
                  (ADVP (RB mainly))
                  (PP (IN by)
                    (NP (NN IL-6))))))))
        (, ,))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN detected)
            (PP (IN in)
              (NP (DT the) (NNP ST)))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP STAT3) (NNP activation))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (JJ synovial) (NN fibroblast) (NN proliferation)
                          (CC and)
                          (NN IL-6) (NN production))
                        (VP (VBG -LSB-)
                          (NP (CD 37) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN regard)))
    (, ,)
    (NP (NNP STAT3))
    (VP (VBZ is)
      (ADJP (JJ critical)
        (PP (IN in)
          (NP
            (NP (DT the) (NN survival)
              (CC and)
              (NN expansion))
            (PP (IN of)
              (NP (NN growth) (JJ factor-dependent) (NN synovial) (NNS fibroblasts))))))
      (S
        (VP (VBG -LSB-)
          (NP (CD 38) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN significance))
      (PP (IN of)
        (NP
          (NP (JJ persistent) (NN STAT3))
          (VP (VBG signaling)
            (PP (IN in)
              (NP (JJ Th1-cell-dominated) (JJ autoimmune) (NN arthritis)))))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN suggested)
          (PP (IN by)
            (NP
              (NP (NNS studies))
              (PP (IN of)
                (NP
                  (NP (DT the) (JJ gp130F759/F759) (NNS mice))
                  (, ,)
                  (SBAR
                    (WHPP (IN in)
                      (WHNP (WDT which)))
                    (S
                      (NP
                        (NP (DT the) (NNP Src) (JJ homology) (JJ phosphatase-2) (JJ binding) (NN site))
                        (PP (IN of)
                          (NP
                            (NP (NNS gp130))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (NP (DT the) (JJ transmembrane) (NN glycoprotein) (NN β) (NN subunit))
                                (PP (IN of)
                                  (NP (DT the) (NNP IL-6) (NN family) (NN cytokine) (NN receptor))))
                              (-RRB- -RRB-))))
                        (, ,)
                        (ADJP (JJ tyrosine)
                          (NP (CD 759)))
                        (, ,))
                      (VP (VBD was)
                        (VP (VBN mutated)
                          (S
                            (VP (TO to)
                              (VP (VB phenylalanine)
                                (NP
                                  (QP (CD -LSB-) (CD 39))
                                  (NNS -RSB-))))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ gp130F759/F759) (NNS mice)))
    (, ,)
    (NP
      (NP (NNP T) (NNS cells))
      (, ,) (RB particularly)
      (NP (DT the) (NNP CD4) (NNP +) (NNP T-cell) (NN subset))
      (, ,))
    (VP (VBP are)
      (ADJP
        (ADJP (RB chronically) (JJ activated)
          (CC and)
          (JJ resistant))
        (PP (TO to)
          (NP (JJ activation-induced) (NN cell) (NN death))))
      (PP (IN through)
        (NP (JJ gp130-mediated) (NN STAT3) (NN activation))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN longevity))
        (PP (IN of)
          (NP (JJ cytokine) (NNS signals))))
      (VP (VBD transduced)
        (PP (IN by)
          (NP (DT the) (NNP JAK)))))
    (: --)
    (S
      (NP (NNP STAT))
      (ADVP (RB pathway))
      (VP (VBZ is)
        (VP (VBN regulated)
          (PP (IN by)
            (NP (DT the) (NNP SOCS) (NN family) (NNS proteins)))
          (S
            (VP (VBG -LSB-)
              (NP (CD 7) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
            (PP (IN from)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP (JJ active) (NNP RA))))))
          (VP (VBD expressed)
            (NP
              (NP
                (NP (JJR higher) (NNS levels))
                (PP (IN of)
                  (NP (NNP SOCS1))))
              (, ,)
              (CC but)
              (NP
                (NP (JJR lower) (NNS levels))
                (PP (IN of)
                  (NP (NNP SOCS3)))))
            (, ,)
            (PP (VBN compared)
              (PP (IN with)
                (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP SOCS1))
      (VP (VBZ prevents)
        (NP
          (NP (NN activation))
          (PP (IN of)
            (NP (NNP JAK))))
        (PP (IN by)
          (ADJP
            (ADJP (RB directly) (JJ binding))
            (PP (TO to)
              (NP (NNP JAK)))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP SOCS3))
      (VP (VBZ inhibits)
        (NP
          (NP (DT the) (NN action))
          (PP (IN of)
            (NP (NNP JAK))))
        (PP (IN by)
          (NP
            (NP
              (ADJP (JJ binding)
                (PP (TO to)
                  (NP (DT the) (NNP Src) (NN homology))))
              (JJ phosphatase-2-binding) (NN domain))
            (PP (IN of)
              (NP
                (NP (NNS receptors))
                (PP (JJ such) (IN as)
                  (NP (CD gp130) (NNS -LSB-)
                    (QP (CD 40) (CD -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP SOCS1)
      (CC and)
      (NNP SOCS3))
    (VP (VBP are)
      (VP (VBN induced)
        (PP (IN by)
          (NP (JJ various) (NNS cytokines)))
        (, ,)
        (PP (VBG including)
          (NP (NN IL-6)
            (CC and)
            (NN IL-10)))
        (, ,)
        (PP (IN as)
          (NP
            (NP (NNS mediators))
            (PP (IN of)
              (NP
                (NP (JJ negative) (NN feedback)
                  (CC and)
                  (NN crosstalk) (NN inhibition))
                (VP (VBG -LSB-)
                  (NP (CD 7) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Recent) (NNS studies))
      (PP (IN with)
        (NP
          (NP (NNS mice))
          (VP (VBG lacking)
            (NP (NNP SOCS3)
              (CC or)
              (NNP SOCS1))))))
    (VP (VBD revealed)
      (SBAR (IN that)
        (S
          (NP (NNP SOCS3))
          (VP (VBZ is)
            (NP
              (NP (DT a) (JJ negative) (NN regulator))
              (PP (IN of)
                (NP
                  (NP (NN IL-6))
                  (VP (VBG signaling)
                    (PP
                      (CONJP (CC but)
                        (RB not))
                      (IN of)
                      (NP
                        (NP (NN IL-10))
                        (VP (VBG signaling))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Studies))
      (PP (IN of)
        (NP (JJ conditional) (NN SOCS3-deficient) (NNS mice))))
    (VP (VBP have)
      (VP (VBN shown)
        (NP
          (NP (DT that) (JJ SOCS3) (NN deficiency))
          (, ,)
          (CONJP (CC but)
            (RB not))
          (NP
            (NP (JJ SOCS1) (NN deficiency))
            (, ,)
            (NP
              (NP (NNS results))
              (PP (IN in)
                (NP
                  (NP (JJ sustained) (NN activation))
                  (PP (IN of)
                    (NP (NNP STAT3))))))))
        (PP (IN in)
          (NP (NN response)))
        (PP (TO to)
          (NP (NNP IL-6) (NNP -LSB-) (CD 8,41) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN analysis))
      (PP (IN of)
        (NP (NN SOCS3-deficient) (NNS macrophages))))
    (VP (VBZ has)
      (VP (VBN indicated)
        (SBAR (IN that)
          (S
            (NP (NNP SOCS3))
            (VP (VBZ is)
              (NP
                (NP (DT a) (JJ crucial) (NN inhibitor))
                (PP (IN of)
                  (NP
                    (NP (DT the)
                      (ADJP (JJ IL-6-induced) (JJ transcriptional))
                      (NN response))
                    (VP (VBG -LSB-)
                      (NP (CD 42) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (NNP SOCS3))
    (VP (VBZ is)
      (ADJP (JJ dispensable))
      (PP (IN for)
        (S
          (NP (PDT both)
            (NP (DT the) (JJ negative) (NN feedback) (NN inhibition))
            (CC and)
            (NP
              (NP (DT the) (JJ immunoregulatory) (NN action))
              (PP (IN of)
                (NP
                  (NP (NN IL-10))
                  (PP (IN in)
                    (NP (NNS macrophages)))))))
          (VP (VBG -LSB-)
            (NP (CD 41) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (NN contrary)))
    (, ,)
    (NP (NNP SOCS1))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB directly))
              (VB inhibit)
              (NP
                (NP (NNS IL-10-mediated))
                (VP (VBG signaling)
                  (NP
                    (QP (CD -LSB-) (CD 43))
                    (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (VBN Increased) (JJ SOCS1) (NN expression))
        (PP (IN in)
          (NP (NNP RA) (NNP CD4) (NNP +) (NNP T) (NNS cells))))
      (VP (MD may)
        (ADVP (RB therefore))
        (VP (VB be)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP (PDT both) (DT the) (VBN impaired) (NNS responsiveness))
                (PP
                  (PP (TO to)
                    (NP (NN IL-10)))
                  (CC and)
                  (PP (TO to)
                    (NP (NN IL-10-mediated) (NN STAT3) (NN activation))))))))))
    (, ,)
    (CC and)
    (S
      (NP (JJ defective) (NN SOCS3) (NN expression))
      (VP (MD may)
        (VP (VB be)
          (ADJP (JJ responsible)
            (PP (IN for)
              (NP
                (NP (JJ persistent) (NN STAT3) (NN activation))
                (PP (IN in)
                  (NP (NN response))))))
          (S
            (VP (TO to)
              (VP (VB serum)
                (NP (NN IL-6))))))))
    (. .)))

(ROOT
  (S
    (NP (EX There))
    (VP (VBZ is)
      (NP (DT a) (NN possibility))
      (SBAR
        (SBAR (IN that)
          (S
            (NP (NNP SOCS1) (NNP induction))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (DT the) (NN ability))
                      (PP (IN of)
                        (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))))
                  (S
                    (VP (TO to)
                      (VP (VB produce)
                        (NP (NNS IFN-γ))))))))))
        (, ,)
        (SBAR (IN because)
          (S
            (NP
              (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
              (PP (IN from)
                (NP (JJ active) (NNP RA))))
            (VP (MD could)
              (VP (VB produce)
                (NP
                  (NP (JJ high) (NNS levels))
                  (PP (IN of)
                    (NP (NNP IFN-γ))))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN presence))
                    (PP (IN of)
                      (NP (NN IL-10)))))))))
        (, ,)
        (CC and)
        (SBAR (IN because)
          (S
            (NP (NNP IFN-γ))
            (VP (VBZ has)
              (VP (VBN been)
                (VP (VBN known)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ potent) (NN inducer))
                      (PP (IN of)
                        (NP (NNP SOCS1) (NNP -LSB-) (CD 32) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (PP (IN of)
        (NP
          (NP
            (NP (NN interest))
            (PP (IN in)
              (NP (DT this) (NN regard)
                (S
                  (VP (TO to)
                    (VP (VB indicate)
                      (SBAR (IN that)
                        (S
                          (NP (JJ polarized) (NNS Th1)
                            (CC and)
                            (NNS Th2) (NNS cells))
                          (VP (VBP express)
                            (NP
                              (NP (JJ high) (NNS levels))
                              (PP (IN of)
                                (NP (NNP SOCS1)
                                  (CC and)
                                  (NNP SOCS3) (NNP mRNA)))))))))))))
          (, ,)
          (ADVP (RB respectively))
          (NP
            (QP (CD -LSB-) (CD 44))
            (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-12-induced) (NNP STAT4) (NN activation))
    (VP (VBZ is)
      (VP (VBG inhibited)
        (PP (IN by)
          (NP (JJ SOCS3) (NN induction)))
        (PP (IN in)
          (NP (JJ Th2) (NNS cells)))
        (, ,)
        (SBAR (IN whereas)
          (S
            (NP (NNP IL-4-induced) (NNP STAT6) (NNP signaling))
            (VP (VBZ is)
              (VP (VBN diminished)
                (PP (IN by)
                  (NP
                    (NP (JJ SOCS1) (NN induction))
                    (PP (IN in)
                      (NP (JJ Th1) (NNS cells)))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP SOCS1)
      (CC and)
      (NNP SOCS3))
    (VP (MD may)
      (ADVP (RB thus))
      (VP (VB have)
        (NP
          (NP
            (NP (JJ important) (NNS roles))
            (PP (IN as)
              (NP (NNS Th1-specific))))
          (CC and)
          (NP
            (NP
              (NP
                (ADJP (JJ Th2-specific) (, ,) (RB mutually) (JJ exclusive) (, ,))
                (JJ cross-talk) (NNS repressors))
              (PP (IN of)
                (NP (DT the) (NN IL-4))))
            (: --)
            (NP
              (NP (NNP STAT6))
              (CC and)
              (NP (DT the) (NN IL-12)))
            (: --)
            (NP
              (NP (NNP STAT4) (NNP signaling))
              (NP (NNS pathways))
              (, ,)
              (ADVP (RB respectively)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NNP Consistent))
        (PP (IN with)
          (NP (DT this) (NN notion))))
      (, ,)
      (NP
        (NP (NNP PB) (NNP T) (NNS cells))
        (PP (IN from)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP (JJ allergic) (NNS diseases))))))
      (ADVP (RB significantly))
      (VP (VBP express)
        (NP
          (NP (JJ high) (NNS levels))
          (PP (IN of)
            (NP (CD SOCS3) (NNS transcripts))))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (NNP SOCS3) (NN expression))
      (VP (VBZ correlates)
        (ADVP (RB well))
        (PP (IN with)
          (NP (NN serum) (NN IgE) (NNS levels)
            (CC and)
            (NN disease) (NN pathology)
            (QP (CD -LSB-) (CD 45))
            (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJR Higher) (NN SOCS1) (NN expression))
      (PP (IN with)
        (NP
          (NP (JJR lower) (NN SOCS3) (NN expression))
          (PP (IN in)
            (NP
              (NP (NNP PB) (NNP CD4) (NNP +) (NNP T) (NNS cells))
              (PP (IN from)
                (NP (NNP RA) (NNS patients)))))))
      (, ,)
      (PP (VBN compared)
        (PP (IN with)
          (NP (JJ healthy) (NNS controls))))
      (, ,))
    (VP (VBZ is)
      (ADVP (RB therefore))
      (ADJP (RB probably) (JJ consistent)
        (PP (IN with)
          (NP
            (NP (PRP$ their) (JJ systemic) (NN bias))
            (PP (IN towards)
              (NP (DT a) (JJ Th1) (NN phenotype))))))
      (, ,)
      (SBAR (IN as)
        (S
          (VP (VBZ has)
            (ADVP (RB previously))
            (VP (VBN been)
              (VP (VBN demonstrated)
                (S
                  (VP (VBG -LSB-)
                    (NP (CD 46-49) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Conclusion) (NNP CD4) (NNP +) (NNP T) (NNS cells))
      (PP (IN from)
        (NP (JJ active) (NNP RA) (NNS patients))))
    (VP (VBP are)
      (VP (VBN characterized)
        (PP (IN by)
          (NP (PRP$ their) (NN resistance)))
        (PP
          (PP (TO to)
            (NP
              (NP (NN IL-10) (NN inhibition))
              (PP (IN of)
                (NP (JJ IFN-γ) (NN production)))))
          (, ,) (RB due)
          (PP (TO to)
            (NP
              (NP (JJ constitutive) (NN STAT3) (NN phosphorylation))
              (CC and)
              (NP (VBN impaired) (NN IL-10-mediated) (NN STAT3) (NN activation)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ defective) (NN STAT3))
      (VP (VBG signaling)))
    (VP (VBZ is)
      (ADVP (RB possibly))
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ SOCS1) (NN predominance))
            (PP (IN over)
              (NP (NNP SOCS3)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT These) (NNS abnormalities))
      (PP (IN in)
        (NP (JJ active) (NNP RA))))
    (VP (VBP are)
      (VP (VBN thought)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN induced)
                (ADVP (RB mainly))
                (PP (IN after)
                  (NP (JJ chronic) (NN exposure)))
                (PP (TO to)
                  (NP
                    (NP (JJ high) (NNS concentrations))
                    (PP (IN of)
                      (NP (NN IL-6)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ limited) (NN efficacy))
      (PP (IN of)
        (NP
          (NP (NN IL-10) (NN treatment))
          (PP (IN of)
            (NP (NNP RA) (NNS patients))))))
    (VP (VBZ -LSB-)
      (NP
        (NP
          (QP (CD 50) (CD -RSB-)))
        (VP (MD may)
          (VP (VB be)
            (VP (VBN explained)
              (PP (IN in)
                (NP (NN part)))
              (PP (IN by)
                (NP (DT the) (NNS unresponsiveness)))
              (PP (TO to)
                (NP
                  (NP (NN IL-10))
                  (PP (IN of)
                    (NP (JJ inflammatory) (NNS cells))))))))
        (, ,)
        (PP (VBG including)
          (NP (NNP T) (NNS cells)))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (NN contrary)))
    (, ,)
    (S
      (NP
        (NP (DT the) (JJ therapeutic) (NN efficacy))
        (PP (IN of)
          (NP (JJ anti-IL-6) (NN receptor) (NN antibody))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN reported)
            (PP (IN in)
              (S
                (NP (NNP RA) (NNS patients))
                (VP (VBG -LSB-)
                  (NP (CD 51) (NNS -RSB-)))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (CD one))
        (PP (IN of)
          (NP
            (NP (DT the) (NNS effects))
            (PP (IN of)
              (NP (DT this) (NN therapy))))))
      (VP (MD may)
        (VP (VB be)
          (S
            (VP (TO to)
              (VP (VB normalize)
                (NP (NNP T) (NNS cells))
                (PP (IN through)
                  (NP
                    (NP (DT the) (NN inhibition))
                    (PP (IN of)
                      (NP (NN IL-6-dependent) (NN STAT3) (NN activation)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (JJR More) (JJ specific) (NN therapy))
        (VP (VBG targeting)
          (NP (JJ STAT3) (NN activation))))
      (VP (MD will)
        (VP (VB be)
          (ADJP (JJ awaited)))))
    (: ;)
    (S
      (PP (IN for)
        (NP (NN example)))
      (, ,)
      (NP
        (NP (DT the) (NN induction))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ SOCS3) (NN gene))
            (, ,)
            (SBAR
              (WHNP
                (NP (DT the) (NN efficacy))
                (WHPP (IN of)
                  (WHNP (WDT which))))
              (S
                (VP (VBZ has)
                  (VP (VBN been)
                    (VP (VBN demonstrated)
                      (PP (IN in)
                        (NP (NN animal) (NNS models)))))))))))
      (VP (VBZ -LSB-)
        (NP (CD 37) (NNS -RSB-))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP
        (NP (NNP Abbreviations) (NNP BSA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ bovine) (NN serum) (NN albumin))))))
      (: ;)
      (NP
        (NP (NNP CRP))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ C-reactive) (NN protein))))))
      (: ;)
      (NP
        (NP (NNP ELISA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ enzyme-linked) (NN immunosorbent) (NN assay))))))
      (: ;)
      (NP
        (NP (NNP Fc))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ crystallazibe) (NN fragment))))))
      (: ;)
      (NP
        (NP (NNP FCS))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ fetal) (NN calf) (NN serum))))))
      (: ;)
      (NP
        (NP (NNP FITC))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN fluorescein) (NN isothiocyanate))))))
      (: ;)
      (NP
        (NP (NNP IFN-γ))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN interferon) (NN gamma))))))
      (: ;)
      (NP
        (NP (NNP IL))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN interleukin))))))
      (: ;)
      (NP
        (NP (NN IL-10R))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ interleukin-10) (NN receptor))))))
      (: ;)
      (NP
        (NP (NN IL-10R1) (NN =) (NN type))
        (NP (CD 1) (JJ interleukin-10) (NN receptor)))
      (: ;)
      (NP
        (NP (NNP JAK))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NNP Janus) (NN kinase))))))
      (: ;)
      (NP
        (NP (NN mAb))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ monoclonal) (NN antibody))))))
      (: ;)
      (NP
        (NP (NNP MHC))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ major) (NN histocompatibility) (NN complex))))))
      (: ;)
      (NP
        (NP (NNP PB))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ peripheral) (NN blood))))))
      (: ;)
      (NP
        (NP (NNP PBMC))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))))))
      (: ;)
      (NP
        (NP (NNP PBS))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ phosphate-buffered) (NN saline))))))
      (: ;)
      (NP
        (NP (NNP PCR))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN polymerase) (NN chain) (NN reaction))))))
      (: ;)
      (NP
        (NP (NNP RA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ rheumatoid) (NN arthritis))))))
      (: ;)
      (NP
        (NP (NNP SOXS) (NNP =) (NNP suppressor))
        (PP (IN of)
          (NP (JJ cytokine) (NNS signaling))))
      (: ;)
      (NP
        (NP (NNP ST))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ synovial) (NN tissue))))))
      (: ;)
      (NP
        (NP
          (NP (NNP STAT))
          (SBAR
            (S
              (VP (SYM =)
                (NP (NN signal) (NN transducer))))))
        (CC and)
        (NP
          (NP (NN activator))
          (PP (IN of)
            (NP (NN transcription)))))
      (: ;)
      (NP
        (NP (NNP Th))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NNP T) (NN helper) (NNS cells))))))
      (: ;)
      (NP
        (NP (NNP TNF-α))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN tumor) (NNS necrosis)))))))
    (ADJP (NN factor) (NN alpha))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (JJ Competing) (NNS interests))
        (NP (DT The) (NN author)))
      (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-)))
    (VP (VBP declare)
      (SBAR (IN that)
        (S
          (NP (PRP they))
          (VP (VBP have)
            (NP (DT no) (VBG competing) (NNS interests))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Authors) (POS '))
      (NNP contributions) (NNP Jiro) (NNP Yamana))
    (VP
      (VP (VBD was)
        (ADJP (JJ responsible))
        (PP (IN for)
          (NP (DT the) (NNS experiments)
            (CC and)
            (NNS data) (NN analysis))))
      (CC and)
      (VP (VBD wrote)
        (NP (DT the) (NN report))))
    (. .)))

(ROOT
  (S
    (NP (NNP Masahiro) (NNP Yamamura))
    (VP
      (VP (VBD was)
        (ADJP (JJ responsible))
        (PP (IN for)
          (NP
            (NP (DT the) (NN planning))
            (PP (IN of)
              (NP (DT the) (NN research))))))
      (CC and)
      (VP (VBD wrote)
        (PRT (RP up))
        (NP (DT the) (NN manuscript))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Akira) (NNP Okamoto))
      (, ,)
      (NP (NNP Tetsushi) (NNP Aita))
      (, ,)
      (NP (NNP Mitsuhiro) (NNP Iwahashi))
      (, ,)
      (CC and)
      (NP (NNP Katsue) (NNP Sunahori)))
    (VP (VBD assisted)
      (NP (DT the) (NNS experiments)))
    (. .)))

(ROOT
  (S
    (NP (NNP Hirofumi) (NNP Makino) (NNP critically))
    (VP (VBP read)
      (NP (DT the) (NN manuscript)))
    (. .)))

(ROOT
  (S
    (NP (NNP Figure)
      (CC and)
      (NNP Table))
    (VP (VBZ captions)
      (NP (NN Figure)
        (NX
          (NP (CD 1))
          (: :)
          (NP
            (NP (JJ Dose) (NN response))
            (PP (IN of)
              (NP
                (NP (NN IL-10) (NN inhibition))
                (PP (IN of)
                  (NP
                    (NP (NN interferon) (NN gamma))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP IFN-γ))
                      (-RRB- -RRB-))))))))
        (NX
          (NX
            (NX (NN production))
            (PP (IN by)
              (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))
            (PP (IN after)
              (NP (NNP CD3))))
          (CC and)
          (NX
            (NP (NNP CD28))
            (VP (VBN costimulation)
              (PP
                (PP (IN in)
                  (NP
                    (NP (NNS patients))
                    (PP (IN with)
                      (NP
                        (NP (JJ rheumatoid) (NN arthritis))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP RA))
                          (-RRB- -RRB-))))))
                (CC and)
                (PP (IN in)
                  (NP
                    (NP (JJ healthy) (NNS controls))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP HC))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP (VBD were)
      (VP (VBN purified)
        (PP (IN from)
          (NP
            (NP
              (NP (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))
              (PP (IN of)
                (NP (CD three) (NNP RA) (NNS patients))))
            (CC and)
            (NP
              (NP (CD three) (NN HC))
              (PP (IN by)
                (NP (JJ positive) (NN selection))))))
        (PP (IN with)
          (NP (JJ anti-CD4) (NN antibody)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 5) (VBG ×) (CD 105) (NNS cells))
          (PP (IN in)
            (NP
              (NP (CD 0.5) (NN ml) (NN culture) (NN medium))
              (PP (IN with)
                (NP
                  (ADJP (CD 10) (NN %))
                  (NNP FCS))))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN stimulated)
        (PP (IN by)
          (NP
            (NP (JJ immobilized) (JJ anti-CD3) (NN antibody))
            (CC and)
            (NP (JJ anti-CD28) (NN antibody))))
        (PP (IN in)
          (NP
            (NP (DT the) (NN presence)
              (CC or)
              (NN absence))
            (PP (IN of)
              (NP
                (NP (VBN diluted) (NN IL-10) (NNS concentrations))
                (PP (IN for)
                  (NP (CD 36) (NNS hours)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Culture) (NNS supernatants))
    (VP (VBD were)
      (VP (VBN measured)
        (PP (IN for)
          (NP
            (NP (NNS concentrations))
            (PP (IN of)
              (NP (NNP IFN-γ)))))
        (PP (IN by)
          (NP (NNP ELISA)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ IFN-γ) (NN production))
      (PP (IN with)
        (NP (NN IL-10))))
    (VP (VBD expressed)
      (NP
        (QP (JJ as) (NN %))
        (JJ IFN-γ) (NN production))
      (PP (IN without)
        (NP (NN IL-10))))
    (. .)))

(ROOT
  (S
    (NP (NNS Values))
    (VP (VBP are)
      (NP
        (NP (DT the) (JJ mean) (JJ ±) (JJ standard) (NN error))
        (PP (IN of)
          (NP (DT the) (NN mean)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Figure) (CD 2))
      (: :)
      (NP
        (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
        (NP (NNP Interferon))
        (PP (VBG gamma)
          (PRN (-LRB- -LRB-)
            (NP (NNP IFN-γ))
            (-RRB- -RRB-))
          (NP
            (NP (NN production))
            (PP (IN by)
              (NP (NNP CD3)
                (CC and)
                (NNP CD28)))))))
    (VP (VBD costimulated)
      (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
      (PP (IN in)
        (NP
          (NP (DT the) (NN presence))
          (PP (IN of)
            (NP (NN IL-10)))))
      (PP
        (PP (IN in)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP
                (NP (JJ rheumatoid) (NN arthritis))
                (PRN (-LRB- -LRB-)
                  (NP (NNP RA))
                  (-RRB- -RRB-))))))
        (CC and)
        (PP (IN in)
          (NP
            (NP (JJ healthy) (NNS controls))
            (PRN (-LRB- -LRB-)
              (NP (NNP HC))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 5) (VBG ×) (CD 105) (NNS cells))
          (PP (IN in)
            (NP
              (NP (CD 0.5) (NN ml) (NN culture) (NN medium))
              (PP (IN with)
                (NP
                  (ADJP (CD 10) (NN %))
                  (NNP FCS))))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN stimulated)
        (PP (IN by)
          (NP
            (NP (JJ anti-CD3) (NN antibody))
            (CC and)
            (NP (JJ anti-CD28) (NN antibody))))
        (PP (IN with)
          (CC or)
          (IN without)
          (NP (CD 1) (JJ ng/ml) (NN IL-10)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Concentrations))
      (PP (IN of)
        (NP
          (NP (NNP IFN-γ))
          (PP (IN in)
            (NP (NN culture) (NNS supernatants))))))
    (VP (VBD were)
      (VP (VBN measured)
        (PP (IN in)
          (NP (NNP duplicate)))
        (PP (IN by)
          (NP (NNP ELISA)))))
    (. .)))

(ROOT
  (S
    (NP (NNP RA) (NNS patients))
    (VP (VBD were)
      (VP (VBN divided)
        (PP (IN into)
          (NP
            (NP (DT those))
            (PP (IN with)
              (NP
                (NP (JJ active) (NN disease))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP
                      (NP (JJ multiple) (JJ inflammatory) (NNS joints))
                      (CC and)
                      (NP (NNP CRP) (NN level) (NNP ≥)))
                    (ADJP (CD 10) (JJ mg/l)))
                  (-RRB- -RRB-))
                (CC and)
                (NP (JJ inactive) (NN disease))
                (PRN (-LRB- -LRB-)
                  (PP (IN in)
                    (NP
                      (NP (NN remission)
                        (CC and)
                        (NNP CRP) (NN level) (NNS ≤))
                      (ADJP (CD 4) (JJ mg/l))))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBP are)
      (VP (VBN represented)
        (PP (IN as)
          (NP
            (NP
              (NP (DT a) (NN box) (NN plot))
              (: ;)
              (NP
                (NP (JJ upper))
                (CC and)
                (NP (JJR lower) (NNS bars))))
            (, ,)
            (NP
              (NP
                (NP (JJ 90th)
                  (CC and)
                  (JJ 10th) (NNS percentiles))
                (, ,)
                (ADVP (RB respectively)))
              (: ;)
              (NP
                (NP (JJ upper))
                (, ,)
                (NP (NN center))))
            (CC and)
            (NP
              (NP (JJR lower) (NNS lines))
              (PP (IN of)
                (NP
                  (NP (NN box))
                  (, ,)
                  (NP (JJ 75th))
                  (, ,)
                  (NP (JJ 50th))
                  (, ,)
                  (CC and)
                  (NP (JJ 25th) (NNS percentiles)))))))
        (, ,)
        (ADVP (RB respectively))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (NP (NN Percentage))
    (PP (IN of)
      (NP (JJ IFN-γ) (NN production)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ IFN-γ) (NN production))
      (PP (IN with)
        (NP (NN IL-10))))
    (VP (VBD expressed)
      (NP
        (QP (JJ as) (NN %))
        (JJ IFN-γ) (NN production))
      (PP (IN without)
        (NP (NN IL-10))))
    (. .)))

(ROOT
  (S
    (NP (NNS Values))
    (VP (VBP are)
      (NP
        (NP (DT the) (JJ mean) (JJ ±) (JJ standard) (NN error))
        (PP (IN of)
          (NP (DT the) (NN mean)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB n))
    (, ,)
    (NP
      (NP (NN number))
      (PP (IN of)
        (NP (NNS samples))))
    (VP (VBD tested))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 3))
    (: :)
    (NP
      (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
      (NP (JJ Cell) (NN surface) (NN expression))
      (PP (IN of)
        (NP
          (NP (NN type))
          (PP
            (PP
              (NP
                (NP
                  (NP (CD 1) (JJ interleukin-10) (NN receptor))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP IL-10R1))
                    (-RRB- -RRB-)))
                (PP (IN on)
                  (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
              (IN from)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP (JJ rheumatoid) (NN arthritis)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP RA))
                  (-RRB- -RRB-))))
            (CC and)
            (PP (IN from)
              (NP
                (NP (JJ healthy) (NNS controls))
                (PRN (-LRB- -LRB-)
                  (NP (NNP HC))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Peripheral) (NN blood) (NN mononuclear) (NNS cells))
    (VP
      (VP (VBD were)
        (VP (VBN stained)
          (PP
            (PP (IN with)
              (NP (JJ anti-IL-10R1) (NN antibody)))
            (CC or)
            (PP (IN with)
              (NP
                (NP (JJ isotype-matched) (NN control) (NN antibody))
                (, ,)
                (VP (VBN followed)
                  (PP (IN by)
                    (NP (NN incubation)))
                  (PP (IN with)
                    (NP (JJ FITC-conjugated) (NNP goat) (JJ anti-mouse) (JJ IgG1) (NN polyclonal) (NN antibody))))
                (, ,))))))
      (CC and)
      (VP (VBD were) (RB then)
        (VP (VBN stained)
          (PP (IN with)
            (NP (JJ phycoerythrin-conjugated) (JJ anti-CD4) (NN mAb))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN expression))
      (PP (IN of)
        (NP (NNP CD4)
          (CC and)
          (NNP IL-10R1))))
    (VP (VBD was)
      (VP (VBN determined)
        (PP (IN by)
          (NP (NN flow) (JJ cytometric) (NN analysis)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Representative) (JJ histographic) (NNS patterns))
      (PP (IN of)
        (NP
          (NP (NN IL-10R1) (NN expression))
          (PP (IN on)
            (NP
              (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
              (PP (IN from)
                (NP
                  (NP (NNP RA) (NNS patients))
                  (CC and)
                  (NP (NNP HC)))))))))
    (VP (VBP are)
      (VP (VBN shown)))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
        (NP (DT The) (NN intensity))
        (PP (IN of)
          (NP (NN IL-10R1))))
      (PP (IN on)
        (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
    (VP (VBD was)
      (VP (VBN expressed)
        (PP (IN as)
          (NP
            (NP (DT the) (NN ratio))
            (PP (IN of)
              (NP
                (NP
                  (NP (DT the) (JJ mean) (NN fluorescence) (NN intensity))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP MFI))
                    (-RRB- -RRB-)))
                (PP (IN of)
                  (S
                    (VP (VBG staining)
                      (PP (IN with)
                        (NP
                          (ADJP (JJ anti-IL-10R1)
                            (PP (TO to)
                              (NP (NN control))))
                          (NN antibody))))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Values))
    (VP (VBP are)
      (NP
        (NP (DT the) (JJ mean) (JJ ±) (JJ standard) (NN error))
        (PP (IN of)
          (NP (DT the) (NN mean)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB n))
    (, ,)
    (NP
      (NP (NN number))
      (PP (IN of)
        (NP (NNS samples))))
    (VP (VBD tested))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 4))
    (: :)
    (NP
      (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
      (NP (NN IL-10-mediated) (NN phosphorylation))
      (PP (IN of)
        (NP
          (NP (NN signal) (NN transducer)
            (CC and)
            (NN activator))
          (PP (IN of)
            (NP
              (NP
                (NP (NN transcription))
                (PRN (-LRB- -LRB-)
                  (NP (NNP STAT))
                  (-RRB- -RRB-)))
              (PP
                (PP
                  (NP
                    (NP (CD 1)
                      (CC and)
                      (CD STAT3))
                    (PP (IN in)
                      (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
                  (IN from)
                  (NP
                    (NP (NNS patients))
                    (PP (IN with)
                      (NP (JJ rheumatoid) (NN arthritis)))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP RA))
                      (-RRB- -RRB-))))
                (CC and)
                (PP (IN from)
                  (NP
                    (NP (JJ healthy) (NNS controls))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP HC))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 5) (JJ ×) (CD 105) (NNS cells))
            (PP (IN in)
              (NP
                (NP (CD 0.5) (NN ml) (NN culture) (NN medium))
                (PP (IN with)
                  (NP
                    (ADJP (CD 10) (NN %))
                    (NNP FCS))))))
          (-RRB- -RRB-)))
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (CC or)
            (IN without)
            (NP
              (NP (NN IL-10))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 1))
                  (CC and)
                  (NP (CD 10) (NN ng/ml)))
                (-RRB- -RRB-)))))))
    (CC and)
    (S
      (NP (NNS cells))
      (VP (VBD were)
        (VP (VBN harvested)
          (ADVP
            (NP (CD 20) (NN min))
            (RB later)))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Whole) (NN cell) (NNS extracts))
      (VP (VBD were)
        (VP (VBN prepared)
          (PP (IN by)
            (S
              (VP (VBG placing)
                (NP (NNS cells))
                (PP (IN in)
                  (NP (NNP SDS) (NN buffer)))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP
          (NP (JJ tyrosine) (NN phosophorylation))
          (PRN (-LRB- -LRB-)
            (NP (NN p-Tyr))
            (-RRB- -RRB-)))
        (PP (IN of)
          (NP (NNP STAT1)
            (CC and)
            (NNP STAT3))))
      (VP (VBD was)
        (VP (VBN detected)
          (PP (IN by)
            (NP (JJ western) (NN blot) (NN analysis))))))
    (. .)))

(ROOT
  (S
    (NP (JJ IFN-γ-stimulated) (NNP Hela) (NNS cells))
    (VP (VBD were)
      (VP (VBN used)
        (PP (IN as)
          (NP
            (NP (DT a) (JJ positive) (NN control))
            (PP (IN for)
              (NP (JJ STAT1) (NN phosphorylation)))))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (NP (NN Percentage))
    (PP (IN of)
      (NP (NN IL-10-activated) (NN STAT3) (NN phosphorylation)))
    (PP (IN in)
      (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))
    (PP
      (PP (IN from)
        (NP (NNP RA) (NNS patients)))
      (CC and)
      (PP (IN from)
        (NP (NNP HC))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NN Protein) (NNS bands))
      (VP (VBD were)
        (VP (VBN quantified)
          (PP (IN by)
            (S
              (ADVP (RB densitometry))
              (VP (VBG using)
                (NP (JJ NIH-Image) (NN analysis))))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP STAT3) (NNP phosphorylation))
      (VP (VBD was)
        (VP (VBN expressed)
          (NP
            (QP (JJ as) (NN %))
            (JJ total) (NNP STAT3) (NNPS protein)))))
    (. .)))

(ROOT
  (S
    (LST (-LRB- -LRB-) (NN c) (-RRB- -RRB-))
    (VP (VB STAT3)
      (NP
        (NP (NN phosphorylation))
        (PP (IN in)
          (NP (NNP ST) (NNP CD4) (NNP +) (NNP T) (NNS cells))))
      (PP (IN from)
        (NP (NNP RA) (NNS patients))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Representative) (NNS results))
      (PP (IN of)
        (NP
          (NP (JJ STAT3) (NN phosphorylation))
          (PP (IN in)
            (NP
              (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
              (PP (IN from)
                (NP
                  (NP
                    (NP (CD three) (JJ synovial) (NN tissue) (NNS samples))
                    (PP (IN of)
                      (NP (NNP RA) (NNS patients))))
                  (CC and)
                  (NP
                    (NP (CD three) (JJ peripheral) (NN blood) (NNS samples))
                    (PP (IN of)
                      (NP (NNP HC)))))))))))
    (VP (VBP are)
      (VP (VBN shown)))
    (. .)))

(ROOT
  (S
    (NP (NNS Values))
    (VP (VBP are)
      (NP
        (NP (DT the) (JJ mean) (JJ ±) (JJ standard) (NN error))
        (PP (IN of)
          (NP (DT the) (NN mean)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB n))
    (, ,)
    (NP
      (NP (NN number))
      (PP (IN of)
        (NP (NNS samples))))
    (VP (VBD tested))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 5))
    (: :)
    (NP
      (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
      (NP (NNP Activation))
      (PP (IN of)
        (NP
          (NP (NN signal) (NN transducer)
            (CC and)
            (NN activator))
          (PP (IN of)
            (NP
              (NP (NN transcription))
              (PRN (-LRB- -LRB-)
                (NP (NNP STAT))
                (-RRB- -RRB-))
              (SBAR
                (WHNP
                  (NP (CD 3))
                  (PP (IN in)
                    (NP (JJ normal) (NN CD4))))
                (S
                  (VP (VBD +)
                    (NP (NNP T) (NNS cells))
                    (PP (IN by)
                      (NP (NN serum) (NN IL-6)))
                    (PP (IN from)
                      (NP
                        (NP (NNS patients))
                        (PP (IN with)
                          (NP
                            (NP (JJ rheumatoid) (NN arthritis))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP RA))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
        (PP (IN from)
          (NP (JJ healthy) (NNS controls))))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 5) (VBG ×) (CD 105) (NNS cells))
          (PP (IN in)
            (NP (CD 0.5) (NN ml) (NN culture) (NN medium))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN stimulated)
        (PP
          (PP (IN by)
            (NP
              (NP
                (ADJP (CD 30) (NN %))
                (NNP RA) (NN serum))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN presence))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (JJ neutralizing) (JJ anti-IL-6) (NN antibody))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP Ab))
                          (-RRB- -RRB-)))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (QP (CD 40) (CD μg))
                          (NN /) (NN ml))
                        (-RRB- -RRB-))))))))
          (CC or)
          (PP (IN of)
            (NP
              (NP
                (NP (NN control) (NN antibody))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD 40) (CD μg))
                    (NN /) (NN ml))
                  (-RRB- -RRB-)))
              (PP (IN for)
                (NP (CD 20) (NN min))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Phosophorylation))
      (PP (IN of)
        (NP (NNP STAT1)
          (CC and)
          (NNP STAT3))))
    (VP (VBD was)
      (VP (VBN detected)
        (PP (IN by)
          (NP (JJ western) (NN blot) (NN analysis)))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (NP (NN Effect))
    (PP (IN of)
      (NP (NN IL-6) (NN pretreatment)))
    (PP (IN on)
      (NP (NN IL-10) (NN inhibition)))
    (PP (IN of)
      (NP
        (NP (JJ IFN-γ) (NN production))
        (PP (IN by)
          (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 5) (VBG ×) (CD 105) (NNS cells))
          (PP (IN in)
            (NP
              (NP (CD 0.5) (NN ml) (NN culture) (NN medium))
              (PP (IN with)
                (NP
                  (ADJP (CD 10) (NN %))
                  (NNP FCS))))))
        (-RRB- -RRB-)))
    (VP
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (CC or)
            (IN without)
            (NP
              (NP (NN IL-6))
              (PRN (-LRB- -LRB-)
                (NP (CD 10) (NN ng/ml))
                (-RRB- -RRB-))))
          (PP (IN for)
            (NP (CD 36) (NNS hours)))))
      (, ,)
      (CC and)
      (VP (VBD were) (RB then)
        (VP (VBN stimulated)
          (PP (IN by)
            (NP
              (NP (JJ anti-CD3) (NN antibody))
              (CC and)
              (NP (JJ anti-CD28) (NN antibody))))
          (PP (IN in)
            (NP
              (NP (DT the) (NN presence)
                (CC or)
                (NN absence))
              (PP (IN of)
                (NP
                  (NP
                    (NP (NN IL-10))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 1) (NN ng/ml))
                      (-RRB- -RRB-)))
                  (PP (IN for)
                    (NP (CD 36) (NNS hours))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Concentrations))
      (PP (IN of)
        (NP
          (NP (NNP IFN-γ))
          (PP (IN in)
            (NP (NN culture) (NNS supernatants))))))
    (VP (VBD were)
      (VP (VBN measured)
        (PP (IN in)
          (NP (NNP duplicate)))
        (PP (IN by)
          (NP (NNP ELISA)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ IFN-γ) (NN production))
      (PP (IN with)
        (NP (NN IL-10))))
    (VP (VBD was)
      (VP (VBN expressed)
        (NP
          (QP (JJ as) (NN %))
          (JJ IFN-γ) (NN production))
        (PP (IN without)
          (NP (NN IL-10)))))
    (. .)))

(ROOT
  (S
    (NP (NNS Values))
    (VP (VBP are)
      (NP
        (NP (DT the) (JJ mean) (JJ ±) (JJ standard) (NN error))
        (PP (IN of)
          (NP (DT the) (NN mean)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB n))
    (, ,)
    (NP
      (NP (NN number))
      (PP (IN of)
        (NP (NNS samples))))
    (VP (VBD tested))
    (. .)))

(ROOT
  (NP
    (NP (NN P-Tyr))
    (, ,)
    (NP (JJ tyrosine) (NN phosophorylation))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 6))
    (: :)
    (NP
      (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
      (NP (DT The) (NN mRNA) (NN expression))
      (PP (IN of)
        (NP
          (NP (NNP SOCS1)
            (CC and)
            (NNP SOCS3))
          (PP (IN in)
            (NP
              (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
              (PP (IN from)
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP
                      (NP
                        (ADJP (JJ RA)
                          (CC and)
                          (JJ healthy))
                        (NNS controls))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP HC))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Total) (JJ cellular) (NNS RNA))
      (VP (VBD was)
        (VP (VBN extracted)
          (PP (IN from)
            (NP (RB freshly) (VBN isolated) (NNP CD4) (NNP +) (NNP T) (NNS cells))))))
    (CC and)
    (S
      (NP
        (NP (NN mRNA) (NN expression))
        (PP (IN of)
          (NP (NNP SOCS1)
            (CC and)
            (NNP SOCS3))))
      (VP (VBD was)
        (VP (VBN analyzed)
          (PP (IN by)
            (NP
              (NP (JJ real) (NN time-PCR) (IN as))
              (VP (VBN described)
                (PP (IN in)
                  (NP (NNPS Patients)
                    (CC and)
                    (NNPS Methods)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Levels))
      (PP (IN of)
        (NP (NNP SOCS1)
          (CC and)
          (NNP SOCS3) (NNS mRNAs))))
    (VP (VBD were)
      (VP (VBN normalized)
        (ADVP (JJ relative))
        (PP (TO to)
          (NP (JJ β-actin) (NN expression)))))
    (. .)))

(ROOT
  (S
    (NP (NNS Values))
    (VP (VBP are)
      (NP (DT the) (JJ mean) (NNP ±) (NNP SEM)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN n) (NN =) (NN number))
      (PP (IN of)
        (NP (NNS samples))))
    (VP (VBD tested))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (NP (NNP Kinetics))
    (PP (IN of)
      (NP
        (NP (NN IL-6-induced) (CD SOCS1) (NN mRNA) (NN expression))
        (PP (IN in)
          (NP (JJ normal) (NNP CD4) (NNP +) (NNP T) (NNS cells)))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP
          (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
          (PP (IN from)
            (NP (NNP HC))))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 5) (VBG ×) (CD 105) (NNS cells))
            (PP (IN in)
              (NP
                (NP (CD 0.5) (NN ml))
                (PP (IN of)
                  (NP
                    (NP (NN culture) (NN medium))
                    (PP (IN with)
                      (NP
                        (ADJP (CD 10) (NN %))
                        (NNP FCS))))))))
          (-RRB- -RRB-)))
      (VP (VBD were)
        (VP (VBN stimulated)
          (PP (IN with)
            (NP
              (NP (NN IL-6))
              (PRN (-LRB- -LRB-)
                (NP (CD 10) (NN ng/ml))
                (-RRB- -RRB-)))))))
    (CC and)
    (S
      (NP (CD SOCS1) (NN mRNA) (NN expression))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (IN at)
            (NP (DT the) (JJ indicated) (NN time)))
          (PP (IN after)
            (NP (NN stimulation))))))
    (. .)))

